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Summary
The synthesis of proteins is an essential process in all living cells that is well regulated
and realized by the ribosome. Three separate topics dealing with aspects of ribosomal
functions in eukaryotes were studied during this PhD thesis using mainly cryo-electron
microscopy (cryo-EM) and single particle data analysis. In the ﬁrst part the cryo-EM
reconstruction of the 60S-eIF6 complex, which is essential in the ribosomal initiation
phase revealed the structural basis of the mechanism of eIF6's anti-association activity.
In the second part, the structures of two eukaryotic 80S Helix-RNCs showed that a-
helix formation is indeed possible in the ribosomal tunnel and that folding is restricted
to distinct tunnel regions. Third, the ribosome-associated chaperone triad of yeast
composed of RAC and Ssb was studied. A ﬁrst cryo-EM structure of the 80S-bound RAC
could be solved, which opens the door for further studies and a better understanding of
co-translational folding events beyond the ribosomal tunnel.
Part I.
Introduction
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1. Ribosomes
In all living cells translation of mRNAs into polypeptides is realized by the ribosome.
Molecular structures of the large ribosomal subunit revealed that these molecular ma-
chines are indeed ribozymes, using mainly RNA to catalyze peptide bond formation
in the active center, the peptidyl transferase center (PTC). During the last few years
a breakthrough in understanding the mechanism of protein synthesis was achieved by
solving a number of ribosomal crystal structures at atomic resolution (Ramakrishnan,
2002). Starting with the ﬁrst high-resolution structure of an archaean 50S subunit (Ban
et al., 2000) and followed by the 30S structure of T. thermophilus (Schluenzen et al.,
2000; Wimberly et al., 2000). Atomic structures of the complete 70S ribosome in diﬀer-
ent functional states (Schuwirth et al., 2005; Selmer et al., 2006; Korostelev et al., 2006;
Berk et al., 2006) and recently with bound ligands (Blaha et al., 2009; Schmeing et al.,
2009; Gao et al., 2009) allowed a detailed understanding of this molecular machine and
its interaction with various ligands. Strikingly, a molecular structure of the eukaryotic
80S ribosome is still missing. The bacterial 70S ribosome has a molecular weight (MW)
of ∼2,4 MDa and consists of a small 30S and a large 50S subunit. In comparison, eu-
karyotic 80S ribosomes have a MW of ∼4 MDa and they are composed of a 40S and 60S
ribosomal subunit, which have additional ribosomal proteins and extra rRNA segments,
referred to as rRNA expansion segments that are mainly found around the periphery
of the subunits. Around 30 % of the total cell mass are ribosomes in bacteria and eu-
karyotes (Kramer et al., 2009). Bacterial ribosomes synthesize proteins with rates of
about 20 aa (amino acids) per second, whereas eukaryotes translate only with a speed of
5-9 aa per second. Protein synthesis is a complicated process that combines high speed
with high ﬁdelity (Green & Noller, 1997) and that occurs in four phases: initiation,
elongation, termination and ribosome recycling. In each step a large number of speciﬁc
translation factors cooperate with the ribosome. One of them is eukaryotic IF6 which
operates during the initiation phase. But not only protein synthesis is realized by the
ribosome, there are data that show a participation of the ribosomal tunnel in folding,
by providing an environment that allows formation of secondary structure elements like
8
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a-helices Woolhead et al. (2004); Kosolapov & Deutsch (2009). However, folding occurs
in- and outside of the ribosomal tunnel. As soon as the nascent polypeptide has left the
ribosomal tunnel, a 'welcome committee' of several factors including chaperones interact
co-translationally with the nascent protein chain.
1.1. The role of eIF6 in translation and 60S ribosome
biogenesis
Eukaryotic initiation factor 6 (eIF6, p27BBP, Tif6p in S. cerevisiae) is an essential 25
kDa protein in archaea (aIF6) and eukaryotes (Si & Maitra, 1999). It is absent in
eubacteria and has a sequence identity of 77 % between yeast and humans (Miluzio
et al., 2009). In wheat germ and mammalian liver it was originally identiﬁed as a
ribosomal anti-association factor and therefore classiﬁed as translation initiation factor
(Russell & Spremulli, 1979; Valenzuela et al., 1982). eIF6 participates in the biogenesis
Figure 1.: Functions of eIF6. | In eukaryotes, eIF6 is involved in the biogenesis of
ribosomes and in translational control. (from (Miluzio et al., 2009))
of ribosomes as well as in translational control (Fig. 1). During the process of ribosome
biogenesis, eIF6 binds to 60S ribosomal subunits and prevents the premature association
with the 40S ribosomal subunit to form the 80S initiation complex. The depletion of
eIF6 in S. cerevisiae is lethal and lead to a slow down of translational activity due to
a loss of available free 60S subunits (Si & Maitra, 1999), consistent with its role as
anti-association factor. It is localized in the nucleus and in the cytoplasm of yeast and
9
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mammalian cells (Sanvito et al., 1999; Lebreton et al., 2006). In the cytoplasm eIF6
is associated with free 60S particles (Si & Maitra, 1999) and in the nucleus it is part
of the 66S pre-ribosomal particles (Horsey et al., 2004), wherefrom it is subsequently
exported together with the mature 60S subunits. Nuclear shuttle was shown to be
regulated in yeast and mammalian eIF6 by phosphorylation of Ser174 (major site) and
Ser175 (minor site) (Basu et al., 2003). In yeast the cytoplasmic release of eIF6 from 60S
subunits is promoted by two factors, the GTPase Eﬂ1 (Eﬂ1p) (Senger et al., 2001)and
Sdo1 (Sdo1p), the yeast ortholog of the SBDS (Shwachman-Bodian-Diamond syndrome)
protein (Menne et al., 2007). By contrast, recycling of eIF6 in mammalian is mediated
by a RACK1 dependent PKC stimulation leading to a phosphorylation of eIF6 at Ser235
(Ceci et al., 2003). The characteristic structure of IF6 is called pentein and is conserved
between yeast and archaea. Five quasi identical a/b subdomains are arranged around
an axis with ﬁve-fold pseudosymmetry (Groft et al., 2000) that is formed by a central
cavity. Interestingly, it has recently been shown that eIF6 can be part of the mammalian
RISC complex (Chendrimada et al., 2007) and that it may play important additional
roles in global translation (Gandin et al., 2008) and tumorigenesis (Sanvito et al., 2000;
Harris et al., 2004).
1.2. Folding inside the ribosomal tunnel
The ribosomal exit tunnel is a universal feature of all ribosomes (Frank et al., 1995;
Ban et al., 2000; Morgan et al., 2000; Halic et al., 2006b). The tunnel spans a length of
80-100 Å, on average only 15 Å wide and composed predominantly of ribosomal RNA
(rRNA). An overall electronegative potential of the tunnel is consistent with the domi-
nating RNA environment(Lu & Deutsch, 2008; Lu et al., 2007). In addition to rRNA,
the extensions of the ribosomal proteins rpL4 and rpL17 (L22p in bacteria) contribute
to formation of the tunnel wall, and form a so-called constriction where the tunnel
narrows to 10 Å ((Ban et al., 2000); 2a). The ribosomal protein rpL39 is present in
eukaryotic and archaeal ribosomes, whereas in bacteria the extension of L23p (rpL25 in
eukaryotes) occupies a similar position near the exit tunnel. Despite its universality, a
functional role for the ribosomal tunnel is only beginning to emerge. For many years, the
ribosomal tunnel was thought of only as a passive conduit for the nascent polypeptide
chain. However, accumulating evidence indicates that, at least for some nascent chains,
the tunnel plays an important and more active role. A number of leader peptides induce
translational stalling in response to the presence or absence of an eﬀector molecule, and
10
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thus regulate translation of a downstream gene (Tenson & Ehrenberg, 2002). Leader
peptides of SecM, TnaC and ErmC are well-characterized bacterial examples, for which
mutations in the leader peptide sequence, or in the interacting ribosomal tunnel compo-
nents can relieve the translational arrest (Gong & Yanofsky, 2002; Nakatogawa & Ito,
2002; Vazquez-Laslop et al., 2008). All these data imply a direct interaction between
speciﬁc residues inside the leader peptide with distinct locations of the ribosomal tunnel.
Dimensions of the tunnel preclude the folding of domains as large as an IgG domain (∼17
kDa), whereas a-helix formation seems feasible ((Voss et al., 2006; Hardesty & Kramer,
2001); see also 2b and c). A transmembrane signal anchor sequence is compacted as it
Figure 2.: Ribosomal exit tunnel. | (a) Overview of the ribosomal tunnel based on
the structure of the archaeal 50S subunit. Fitting of an a-helix (b) and an IgG
domain (c) into the ribosomal tunnel. Sterical clashes appear in (c). (adapted
from (Voss et al., 2006))
traverses the tunnel, studied by Fluorescence resonance energy transfer (FRET), which
indicates a-helix formation in the tunnel (Woolhead et al., 2004). Interestingly, in this
study the compaction of the transmembrane nascent chain was lost upon exiting the
tunnel, suggesting that the tunnel itself plays a pivotal role in stabilizing the proposed
helical conformation. Independent biochemical analysis also support the potential of
the nascent chain to adopt compacted or a-helical conformations inside the tunnel and
11
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have even identiﬁed speciﬁc regions where compaction is favored (Kosolapov et al., 2004;
Lu & Deutsch, 2005b,a). Assuming that folding of secondary structure elements in the
ribosomal tunnel is possible, the subsequent action of downstream acting cytosolic chap-
erones would be inﬂuenced, because only unfolded parts are recognized, and thus the
tunnel could act as the ﬁrst part in the folding pathway with chaperone-like function.
12
2. Molecular chaperones
Many newly synthesized proteins require the assistance of molecular chaperones to ef-
ﬁciently fold into their characteristic three-dimensional structure. Chaperones protect
their non-native protein substrates from aggregation and misfolding, but they do not
contribute conformational information to the folding process. So the steric information
of a protein is encoded in its primary structure and the eﬃciency of this assisted self-
assembly process is enhanced by chaperones (Ellis & Hartl, 1999). Molecular chaperones
Figure 3.: Cytosolic chaperone system. | Overview of the travel of a newly synthesized
protein through the cytosolic chaperone system in the three kingdoms of life.
Besides the great diversity of components in chaperone-assisted folding it utilizes
by the same principle. (from (Hartl & Hayer-Hartl, 2002))
are present in the cytosol and in eukaryotic organelles such as ER, mitochondria and
chloroplasts. Based on the mechanism cytosolic chaperones can be structured in two
classes, chaperonins and small chaperones. Chaperonins are large, cylindrical complexes
with a deﬁned inner compartment which provides an isolated environment for folding of
13
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protein domains or whole proteins (Horwich et al., 2007). In contrast, the smaller chap-
erones assist in folding of nascent and newly synthesized polypeptide chains by holding
them in a folding competent state (Hartl & Hayer-Hartl, 2002). The ﬁrst chaperones
which interact with newly synthesized proteins already after the nascent chain emerges
from the ribosomal exit tunnel are nascent chain-binding chaperones, such as Hsp70s
in eukaryotes and trigger factor (TF) in prokaryotes. These chaperones can be sub-
divided into ribosome-associated chaperones and others which do not directly bind to
ribosomes, but act downstream by binding longer nascent chains. In all three kingdoms
of life a chaperone network in the cytosol exists, where many newly synthesized proteins
are guided through and which involves the action of nascent chain-binding chaperones,
and subsequently chaperonins (Figure 3). Misfolding and aggregation of proteins in liv-
ing cells are known to be the reason for misfolding diseases (Barral et al., 2004) and
also involved in aging process (Cohen et al., 2006). Classic examples are neurodegen-
erative diseases, like Huntington's and Alzheimer's disease in humans. Apart from the
potential of chaperones in treatment of diseases associated with protein misfolding they
are interesting for many biotechnological processes, especially for recombinant protein
production.
2.1. Ribosome-associated chaperones
One of the major challenges for the cell is to prevent aggregation and misfolding of
newly synthesized proteins. A highly crowded cytosolic environment with concentra-
tions of 300-400 g/l of proteins and other macromolecules in E. coli, leads to excluded
volume eﬀects (macromolecular crowding) that is predicted to enhance aggregation of
non-native protein chains (van den Berg et al., 1999). In general, macromolecular crowd-
ing provides a non-speciﬁc driving force for macromolecular association (Minton, 2000)
and for interactions with molecular chaperones (Martin & Hartl, 1997). It is thought
that during translation on polyribosomes the tendency for aggregation is strongly in-
creased, due to the close proximity of nascent chains of the same type with non-native,
unfolded features (Frydman, 2001). This could be a potential reason for the requirement
of ribosome-associated chaperones, which act directly at the exit tunnel to prevent ag-
gregation and hold nascent chains in a folding-competent conformation (Hartl & Hayer-
Hartl, 2002). The bacterial trigger factor is the best characterized ribosome-associated
chaperone. It is only found in prokaryotes and chloroplasts. Trigger factor is a 48 kDa
protein that binds to ribosomes in an ATP-independent way in a 1:1 stoichiometry.
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Nascent chains as short as 57 aa can be crosslinked to TF, thus it is the ﬁrst bacterial
chaperone interacting with newly synthesized nascent chains (Hesterkamp et al., 1996).
The preferred binding motif of TF consists of short hydrophobic sequences enriched
in basic and aromatic residues (Patzelt et al., 2001). The bacterial Hsp70 DnaK has
partially overlapping chaperone function with TF. A deletion of either DnaK or TF is
tolerated by E. coli but a double deletion is lethal, showing the functional redundancy
amongst the components of the nascent chain-binding chaperone system (Teter et al.,
1999; Deuerling et al., 1999; Hartl & Hayer-Hartl, 2002). Recent studies showed that
TF interacts with ribosomes and nascent chains in a dynamic reaction cycle, where the
presence and nature of the nascent chain itself modulates the timing of TF binding to
ribosomes (Kaiser et al., 2006; Raine et al., 2006; Rutkowska et al., 2008). The mech-
anistic details how TF exactly assists in folding of nascent polypeptide chains has not
been clariﬁed yet. The eukaryotic cytosol lacks TF but has evolved a Hsp70-Hsp40 based
Figure 4.: Ribosome-associated chaperones vary from bacteria to eukaryotes. |
Prokaryotes have only TF, whereas eukaryotes dispose of a more complex Hsp70
based system.
system that assists the early folding events (Fig. 4). Besides the Hsp70 based ribosome-
binding chaperones, the heterodimeric nascent polypeptide-associated complex (NAC)
is present in eukaryotes. The dimeric a/b NAC complex binds to short nascent chains
and ribosomes in a 1:1 stoichiometry, whereas its ß-subunit mediates ribosome binding
(Wiedmann et al., 1994; Fünfschilling & Rospert, 1999; Beatrix et al., 2000). However,
there is no direct evidence for a role of NAC in co-translational folding apart from its
ribosome interactions.
15
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Hsp70 chaperones
Apart from the ribosome-associated chaperones Ssz (Ssz1p in S. cerevisiae) and Ssb1/2
(Ssb1p and Ssb2p in yeast), there are four other non-ribosome-binding Hsp70s known in
the cytosol of yeast, namely Ssa1-4 (Ssa1-4p). In addition, there are the Hsp70 relatives
Sse1 and Sse2 in the yeast cytosol (Sse1/2p; Hsp110 chaperones). Common structural
features of Hsp70 chaperones are the ∼45 kDa N-terminal ATPase domain (NBD) and a
∼15 kDa C-terminal substrate binding domain (SBD), which are connected by a ﬂexible
linker. The best studied Hsp70 is DnaK from E. coli. It binds preferentially to around
seven aa long target sequences with a hydrophobic core that is ﬂanked by basic residues
(Rüdiger et al., 1997). Binding and release of unfolded substrates to Hsp70 chaperones
are controlled by an ATPase cycle, in cooperation with Hsp40 cofactors and nucleotide
exchange factors (NEFs). The known NEFs show a great diversity. Interestingly, Hsp110
was shown to act as NEF for canonical Hsp70s in yeast (Dragovic et al., 2006; Raviol
et al., 2006). The Hsp70 chaperones are known to be ﬂexible and show an enormous
range of conformational changes depending on their nucleotide and substrate binding
state (Saibil, 2008). So far, there are only two full-length crystal structures of Hsp70
family members available, one of bovine Hsc70 in a nucleotide-free state (Jiang et al.,
2005) and the other of the yeast Sse1 in an ATP-bound state (Liu & Hendrickson, 2007).
Hints for a direct substrate interaction of the NEF Sse1 and a cooperation of Hsp110
and Hsp70 in the protein folding cycle was provided by two co-crystal structures of
Hsp110-Hsp70 complexes (Polier et al., 2008; Schuermann et al., 2008).
2.2. The ribosome-associated chaperone triad in S.
cerevisiae
The eukaryotic ribosome-associated factors are best characterized for S. cerevisiae (Kramer
et al., 2009). Yeast has several ribosome-associated protein biogenesis factors (RPBs )
that interact and modify co-translationally the nascent chain, such as chaperones (Ssb
and RAC), NAC, SRP (signal recognition particle) and modifying enzymes, for instance
methionine aminopeptidase Map (Map1 and Map2) and the N-terminal acetyltransferase
NatA, involved in Na-acetylation (Raue et al., 2007). The ribosome-associated chaper-
ones Zuo (Zuo1p or Zuotin), Ssz and Ssb are genetically linked in S. cerevisiae and form
a functional triad (Gautschi et al., 2002). Yeast mutants lacking either all or one of the
three genes show the same phenotype involving slow growth, cold sensitivity and hy-
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persensitivity to cations and translation-inhibiting antibiotics, like the aminoglycoside
paromomycin (Hundley et al., 2002; Gautschi et al., 2002). The Hsp40 homolog Zuotin
and the Hsp70 homolog Ssz form the stable ribosome-associated complex (RAC), which
is anchored to yeast ribosomes via Zuotin (Gautschi et al., 2001). RAC is also found in
molecular
chaperone
organism
% per
ribosome
ribosome binding properties
nascent chain binding
properties & Function
TF
(ribosome-associated
chaperone)
Bacteria 170
- interacts with L23p of the 70S
- Kd ≈1 µM
- sequence modulates binding
(hydrophobic binding motif)
- increased aﬃnity for long chains
DnaK
(non-ribosome-binding
Hsp70)
Bacteria 100-200 - interacts only with nascent chains
- independent of chain length
- can replace TF; deletion of DnaK
and TF is lethal in E.coli
Ssb (Ssb1/2)
(fungal-speciﬁc,
ribosome-associated
Hsp70)
Eukaryotes 89-300
- binding mainly mediated by nascent
chain
- salt sensitive interaction with 80S
- no binding motif known and no
binding to peptide substrates in vitro
- ATPase activity
RAC
(ribosome-associated
chaperone)
Eukaryotes 27
- Zuo interacts via rpL31 and rRNA
- dynamic binding to 80S
- no interaction with nascent chain
shown
- no ATPase activity of Ssz
- J-protein partner of Ssb
Table 1.: Properties of molecular chaperones in bacteria and yeast. (adapted form
(Giglione et al., 2009)).
higher eukaryotes, where Hsp70L1 stably interacts with the J-protein MPP11 to form
mammalian RAC (mRAC) (Otto et al., 2005) (Fig. 4). The two almost identical Hsp70
chaperones Ssb1/2 diﬀer only in four amino acids. In contrast to RAC, Ssb interacts in
addition to the ribosome also with the nascent polypeptide chain (Pfund et al., 1998;
Raue et al., 2007). It can be crosslinked to short nascent chains having a length of
only 54 aa, meaning that around 10-15 residues emerge from the tunnel (Hundley et al.,
2002; Gautschi et al., 2001). Ssb seems to be a fungal-speciﬁc Hsp70 with unspeciﬁc
substrate spectra, showing an overall homology of only 60 % and 48 % to Ssa and DnaK,
respectively (Pfund et al., 2001). Zuotin can only act as J-protein partner for Ssb and
stimulate its ATP hydrolysis when it is in complex with Ssz, thus forming functional
RAC (Huang et al., 2005). RAC is positioned near the ribosomal exit tunnel via a mixed
interaction, involving the protein rpL31 (Rpl31p in S. cerevisiae, no bacterial homolog)
and exposed rRNA elements (Peisker et al., 2008). The function of the unusual Hsp70
Ssz in the chaperone triad of yeast is still enigmatic. It is not an ATPase in vitro and
the in vivo function is independent of RAC formation, as well as the binding of ATP and
of peptide substrates (Conz et al., 2007). The current understanding of the RAC-Ssb
17
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chaperone system in yeast is based on biochemical studies. Structural data which could
provide an access to a mechanistic understanding of the eukaryotic ribosome-associated
chaperone system are still missing so far.
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3. Cryo-EM
Cryo-EM has been established during the last years as the third method in structural
biology, besides X-ray crystallography and NMR spectroscopy (Frank, 2002). All three
methods are capable of solving structures of biological macromolecules to atomic or
sub-nanometer resolution. The strength of cryo-EM, compared to NMR and crystallog-
raphy, is the ability to get structural information of biological complexes in its native
environment, using only tiny amounts of sample (µg range) and being not limited by
the size of the investigated molecule. A large amount of pure sample is needed to get
suitable crystals and also for NMR spectroscopy a pure, highly concentrated and isotope
labeled sample is essential. Usually the complex of interest should be bigger than 150
kDa to get the signal-to-noise ratio (SNR) required in cryo-EM. In contrast to cryo-EM,
NMR spectroscopy is highly limited by the size of the molecule, whereas X-ray crys-
tallography can manage also huge molecular assemblies, like 70S ribosomes. Still X-ray
crystallography and NMR are the only source, being capable to provide atomic details of
a biological molecules. Taken together, the three structure methods have their intrinsic
assets and drawbacks but cryo-EM is building the bridge to combine atomic information
of crystal structures with intermediate resolved cryo-EM maps of the whole complex.
The docking of atomic structures into cryo-EM reconstructions allows an interpretation
of large multi-component assemblies, such as the ribosome with diﬀerent ligands, at a
molecular level.
3.1. Cryo-EM and single-particle analysis
Biological molecules in cryo-EM are weak phase objects with a poor phase contrast re-
sulting in a low overall contrast, contrary to amplitude objects in negative stain EM.
The cryo-EM sample is only embedded in its aqueous environment, and is therefore not
stained. The contrast is further decreased by the small diﬀerence of the density between
protein molecules with only 1,3 g/cm3 and the surrounding water with 1 g/cm3. The
sample is usually taken directly from the buﬀer solution and applied on a carbon coated
19
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grid. Blotting is needed to get thin ice layers. Afterwards the blotted grid is ﬂash
frozen in liquid ethane. Rapid cooling of the aqueous sample with rates of more than
100.000°C/s leads to the formation of amorphous ice. The random orientation of water
molecules, comparable to liquid water, is preserved in the sample and no crystal lattice
can be formed during the quick cooling procedure. A dataset of the vitriﬁed sample
is collected on a liquid nitrogen cooled transmission electron microscope (TEM) at low
dose conditions, using around 20 e−/Å2 (see Fig. 5). Data can be either recorded on
CCDcamera or ﬁlms. In order to digitize them, ﬁlms have to be scanned at high reso-
lution. With the help of computer clusters the digitized particle images will be aligned,
meaning that a common motif contained in the particle images is brought into register.
A variety of software packages are available for processing of the data, most widely-used
are SPIDER (Frank et al., 1996), EMAN (Tang et al., 2007), IMAGIC (van Heel et al.,
1996), FREALIGN (Grigorieﬀ, 2007), XMIPP (Sorzano et al., 2004) and in the near
future SPARX (Hohn et al., 2007). The result of the alignment is the information of
Figure 5.: Workﬂow in cryo-EM. | The way from sample preparation to 3D reconstruction
and ﬁnal interpretation.
the three Euler angles and the x,y-shifts of each particle in the dataset. In the next
step this angular information is used for the backprojection of the particle images to get
a 3D reconstruction of the observed molecule. To improve the resolution of the recon-
struction a reﬁnement is needed, which is an iterative process with coupled rounds of
alignment and backprojection (Fig. 6). If a reference reconstruction is available, ﬁrst
choice are reference-based alignment techniques like projection matching (Penczek et al.,
1994). For ab initio structure determination, reference-free alignment methods have to
be used, such as random conical tilt (Radermacher et al., 1987) or common line methods.
A reﬁnement round with SPIDER using projection matching, comprises the following
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important steps: ﬁltering and masking of the reference volume, generating pre-aligned
stack ﬁles of the particle images, CTF (contrast transfer function) distortion of only
the generated reference projections, alignment based on calculated CCFs between the
reference projections and the experimental projections, and ﬁnally a backprojection of
the experimental images using the angle and shift informations of the last alignment
round (Fig. 6).
Figure 6.: Reference based reﬁnement with SPIDER. | Single particle analysis using
the method of projection matching based on cross-correlation function (CCF)
for the reﬁnement of cryo-EM datasets. Flow-chart of processing and reference-
based alignment using defocus groups.
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3.2. Limiting aspects in cryo-EM
Heterogeneity of datasets
An important assumption in single-particle analysis is that all experimental 2D-projections
represent randomly orientated projections derived from the same 3D-structure (Fu et al.,
2007), which means that the sample is highly homogeneous in terms of conformation
and composition. Cryo-EM reconstructions of heterogeneous datasets with particles that
originate from the same molecule in diﬀerent conformations result in a fragmented or
even invisible density for the ﬂexible part of the complex, caused by a loss of density
information due to conformational averaging (Penczek et al., 2006). However, the rea-
son of the problem in ribosomal dataset is that single particles like the ribosome have
on the one hand in most of the cases a much bigger size than the bound ligand and
on the other hand the ligand has a small or even no eﬀect on the conformation of the
ribosome, which could be used for classiﬁcation. Therefore, the alignment is dominated
by the large projected potential of the ribosome, leading to an averaging eﬀect for bound
ligands that have itself conformations independent of the ribosome (Spahn & Penczek,
2009). In principle there are two ways of sorting cryo-EM datasets into sub-datasets (also
termed groups or classes) according to their similarities: supervised and unsupervised
sorting. Supervised sorting is based on prior biochemical or structural knowledge about
the sample, therefore an existing 3D reference is used to ﬁnd particle projections inside
the dataset that show high similarity to the oﬀered template and can thus classify the
dataset. No additional knowledge is needed for unsupervised sorting methods, because
they use only the intrinsic information provided by the dataset and allow a classiﬁca-
tion without a pre-existing template, whereby bias arising from an external reference is
minimized or even avoided (Spahn & Penczek, 2009). Most of the unsupervised sorting
methods are based on multivariate statistical analysis at 2D level, such as correspon-
dence analysis (CA), principal component analysis (PCA) or K-means clustering. The
sorting method 'focused classiﬁcation' (Penczek et al., 2006) uses ﬁrst the bootstrap 3D
variance analysis to estimate the voxel-by-voxel variance of the dataset to locate regions
of high variance, which is then used to place a 3D spherical mask that deﬁnes the region
for the focused sorting. The classiﬁcation is focused exclusively on regions with localized
high 3D variance, whereby the data are classiﬁed into homogeneous datasets on 2D pro-
jection level within regions outlined by the respective 2D masks (Penczek et al., 2006).
The resulting classiﬁed volumes were used as a template for an unsupervised sorting by
multireference 3D alignment of the complete dataset (Spahn & Penczek, 2009; Schuette
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et al., 2009; Penczek et al., 2006).
Resolution
There is no physical based resolution criterion in cryo-EM, like it exists in X-ray crystal-
lography. The resolution is measured by dividing the dataset into two random half-sets
and the independently resulting reconstructions are compared along shells in 3D Fourier
space (called Fourier shell correlation, FSC). The most commonly used criterion is the
0.5 FSC cutoﬀ value where the resolution is measured at a CCC (cross-correlation co-
eﬃcient) threshold value of 0.5, which is equivalent to a S/N ratio of only 1, normally
found in unprocessed raw data (Frank, 2002). During the last years some cryo-EM re-
constructions achieved near-atomic resolutions, with particles of high symmetry leading
the way, for instance GroEL (≥ 4 Å) having a 14-fold symmetry (Ludtke et al., 2008),
high symmetric viruses (∼ 4 Å) (Chen et al., 2009; Zhang et al., 2008) and unsymmetric
particles like the ribosome (∼ 6 Å). Clearly, the accuracy of docking stands and falls
with the resolution of the underlying cryo-EM reconstruction and thus the provided
structural information that is eﬀectively resolved in the map and that can be used for
interpretation. Resolution is in general a limiting parameter in cryo-EM that can be
partially overcome by the use of hybrid methods, meaning an interpretation by docking
of X-ray structures into the cryo-EM map (Rossmann et al., 2005). The ﬁtting can be
done either manually by rigid-body docking or with the help of software packages, which
can be based on comparative modeling and ﬂexible ﬁtting (Topf et al., 2008) or that use
molecular dynamics (MD) simulations with force ﬁelds to ﬁt the atomic structure into
the density, such as the program MDFF (Trabuco et al., 2008, 2009).
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4. Aims of the study
The molecular mechanism of the ribosomal anti-association activity of the small protein
eIF6 is not yet understood. One of the aims of this PhD thesis was thus to determine
a reconstruction of a 60S-eIF6 complex by means of cryo-EM analysis. The structure
of this complex would allow a detailed understanding of eIF6's binding site and most
likely reveal informations to understand its anti-association activity and how the release
of eIF6 is accomplished for its recycling.
The second project of this thesis was focused on the question if a-helical structure can
fold inside the ribosomal tunnel. Up to now, this long-standing question has been ad-
dressed exclusively with biochemical and biophysical methods, indicating that secondary
structure elements can indeed form inside the tunnel. In this part of the work we aimed
to analyze a well characterized a-helical element as part of the nascent chain inside the
ribosomal tunnel, using cryo-EM and single particle analysis, to provide structural based
evidence to the problem. The co-translational formation of secondary structure in the
very ﬁrst environment of a 'new-born' protein would extend the view of the ribosomal
tunnel towards a chaperone-like function that could have important implications for
the recognition of signal-sequences and for chaperone assisted folding events beyond the
ribosomal tunnel.
The aim of the third part of this work was to characterize the co-translational acting
chaperone triad of yeast, consisting of RAC and Ssb, with the help of diﬀerent structural
techniques. Structural data of eukaryotic ribosome-associated chaperones are still miss-
ing, which would enable us to understand the function and the interplay of this Hsp70
based chaperone system. The results could be compared to the well characterized but
more simpler system of the bacterial trigger factor that is currently used as a basis for
models of co-translational acting factors at the ribosomal tunnel exit and could possibly
help to extend the understanding of ribosome-associated factors in eukaryotes.
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Results and Discussion
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5. Structure of the 60S-eIF6
complex
5.1. Speciﬁc aim
Most regulation takes place at the ﬁrst stage of translation during the phase of initiation
(Sonenberg & Hinnebusch, 2009). Allocation of free 60S ribosomal subunits into the
translation cycle is a prerequisite for initiation that needs to be regulated. The conserved
and essential protein eIF6 is known to act as a ribosomal anti-association factor and
prevents unregulated association of 40S and 60S subunits to inactive 80S particles.
So far, the molecular basis of the divers eIF6 activities in vivo, involving its interac-
tion with the 60S subunit and the resulting ribosomal anti-association activity are only
poorly understood (Miluzio et al., 2009). The aim of this study was to gain a better
understanding of the molecular basis that underlie its anti-association activity. For this
reason, a homogeneous 60S-eIF6 complex from S. cerevisiae was studied using cryo-EM
and single-particle analysis.
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5.2. Sample preparation and reconstitution
The two components of the 60S-eIF6 complex were separately puriﬁed (Michael Blau).
The full length gene Tif6 that encodes the protein eIF6 from S. cerevisiae was cloned into
a pCRT7/NT-TOPO vector. eIF6 was heterologous overexpressed in E. coli BL21(DE3)
cells and puriﬁed via a N-terminal His6-tag. After induction with IPTG, the cells were
grown overnight at room temperature (RT). Cells were harvested by centrifugation,
resuspended in lysis buﬀer and subsequently lysed. The lysate was cleaned by centrifu-
gation and loaded onto a His-Talon column for puriﬁcation. Eluted fractions were pooled
and ﬁnally puriﬁed using gelﬁltration. Puriﬁed eIF6 was checked for activity with an
anti-association activity assay, as described previously (Si & Maitra, 1999; Groft et al.,
2000). Yeast 80S ribosomes were incubated with ten fold excess of eIF6 at 30°C for
5 minutes in dissociation buﬀer, containing 250 mM KCl and 1 mM Mg(OAc)2. The
reaction was then diluted to around 5 mM Mg(OAc)2 and loaded onto a 5-30 % sucrose
gradient. The 60S peak was fractionated and large ribosomal subunits were pelleted
by ultra-centrifugation in a next step. Pellets were resuspended in buﬀer, containing
100 mM KCl and 2.5 mM Mg(OAc)2. Samples for cryo-EM were prepared using the
pelleted 60S subunits, which were mixed with around ﬁve fold excess of eIF6 to ﬁnally
reconstitute the 60S-eIF6 complex in low salt buﬀer A, containing 100 mM KCl and 2.5
mM Mg(OAc)2 (for details see Material and Methods).
5.3. Cryo-EM analysis
A dataset of the 60S-eIF6 complex was collected under low dose conditions on a nitrogen
cooled Tecnai F30 ﬁeld emission gun electron microscope. Initially, the dataset yielded
to 107,000 particles after particle selection with the programs WEB and SIGNATURE
(Chen & Grigorieﬀ, 2007). The SPIDER software package (Frank et al., 1996) was used
to further process the data. The 60S-eIF6 dataset was used for the ﬁnal CTF-corrected
3D-reconstruction with a determined resolution of 11.8 Å, according to 0.5 FSC criterion
(8.5 Å, 3sv criterion) (Fig. 7b). The cryo-EM reconstruction of the 60S-eIF6 complex
from S. cerevisiae reveals an additional and characteristic ﬁve-fold density for eIF6 in
the intersubunit space of the 60S ribosomal subunit (Fig. 7a). The pseudosymmetric
star-like pentein structure (Groft et al., 2000) of eIF6 is resolved by the cryo-EM map
(Fig. 7c). Thus the map allows to locate and interpret the binding site of eIF6 on
the 60S (Fig. 7d). The ribosomal protein rpL23 (RpL23p in S. cerevisiae, L14p in
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Figure 7.: Cryo-EM reconstruction and docking of eIF6. | (a) Localization of eIF6
(orange) in the cryo-EM reconstruction of the 60S-eIF6 complex. The map is
shown in the classical crown view. (b) Resolution curve with 0.5 FSC cutoﬀ
marked. (c) Isolated eIF6 density. (d) Fitted eIF6 structure docked into the
EM-density (mesh). (60S (gray); eIF6 (orange))
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E. coli) can be identiﬁed as the main interaction partner of eIF6, which is located at
the intersubunit surface of the 60S. This binding site appears to be conserved between
eukaryotes and archaea, since it is in agreement with a similar binding site that has
recently been suggested for the archaeal aIF6 on the basis of chemical cross-linking and
RNA protection experiments (Benelli et al., 2009). The crystal structure of eIF6 from
S. cerevisiae (PDB entry 1G62, Groft et al. (2000) was taken as basis for ﬂexible ﬁtting
into the assigned EM density for eIF6, using the software Flex-EM (Topf et al., 2006).
The eIF6 binding interface with the 60S is in good agreement with previously published
Figure 8.: eIF6 binding site. | Side views, showing the eIF6 binding site on the 60S
subunit. Thumbnails show the respective orientation. Note the phosphorylation
site Ser174 and the main binding partner rpL23.
genetic data. The region of the TIF6 suppressor mutations that rescue sdo1∆ cells were
found on the same site as the assigned eIF6 binding region (Menne et al., 2007). To
ﬁt the density, the C-terminal part of rpL23 was adjusted leading to a small inward
movement of the helical C-terminus of rpL23 relative to the conformation observed in
the 80S ribosome. The hydrophobic C-terminal interaction surface of rpL23 is highly
conserved and interacts with the helical binding region of eIF6, both of them show a high
degree of conservation. In addition, the neighboring ribosomal protein rpL24 (RpL24p in
S. cerevisiae, L24e in H. marismortui) and the highly conserved sarcin-ricin loop (SRL)
contribute in the interaction with eIF6 (Fig. 8).
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5.4. Mechanism of eIF6-mediated inhibition of
ribosomal subunit joining
The anti-association activity of eIF6 is preventing that the 40S subunit binds prema-
turely to the 60S ribosomal subunit. How can this essential function be accomplished,
by the binding of eIF6 to the 60S ribosomal subunit?
When the 40S subunit in its 80S-bound conformation is superimposed with the eIF6-
60S complex, it is evident that both binding partners share a common binding region
with the 60S subunit and can therefore not bind together (Fig. 9). A large part of the
Figure 9.: Binding of eIF6 prevents 40S association. | Cryo-EM map of the 60S-eIF6
complex superimposed with the 40S subunit in the 60S-bound conformation.
Close-up view of the interfering region with the 40S, which is indicated as yellow
shadow mark. (60S (gray); eIF6 (orange))
eIF6 density would sterically clash with the rRNA of the 40S subunit, explaining the
mutually exclusive binding by simple steric hindrance (Fig. 9). The position of eIF6
at the 60S subunit surface coincides exactly with the dynamic intersubunit bridges B6,
formed by the C-terminal region of the ribosomal protein rpL23 (Spahn et al., 2001).
Therefore, when eIF6 is bound to the 60S subunit the bridge B6 and the nearby located
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bridge B5a, both formed by rpL23, are directly aﬀected. In addition, the surrounding
Figure 10.: Intersubunit bridges in the vicinity of eIF6. | The binding position of
eIF6 on the 60S coincides directly with bridge B6. (intersubunit bridges in red)
intersubunit contacts B7, B3 and B5b can no longer be formed due to sterical hindrance,
resulting in the observed highly eﬃcient prevention of subunit joining (Fig. 10). The
conserved phosphorylation sites of yeast eIF6, formed by the two residues Ser174 and
Ser175 (Basu et al., 2003), are located at the accessible surface of the bound eIF6, which
is not involved in the interaction with the 60S subunit (Fig. 7a and d). Also the C-
terminal nuclear localization sequence, which was not visualized in the crystal structure,
would be located at the accessible outer surface of eIF6.
5.5. Release of eIF6 by the yeast GTPase Eﬂ1,
implications from a model
The elongation-factor like GTPase Eﬂ1 (Eﬂ1p) from yeast, that is crucial for the release
of eIF6, is highly homologous to the translation elongation factor eEF2 (Senger et al.,
2001). Therefore, it is safe to assume that they share a very similar binding site (Grain-
dorge et al., 2005), which is known for eEF2 (Spahn et al., 2004) to be the canonical
factor binding site. Since the interaction for eEF2 with the 80S ribosome is known
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Figure 11.: Release of eIF6 by Eﬂ1 can be explained by a model of 60S-bound
Eﬂ1. | (a) Putative binding of modeled eEF2-like GTPase Eﬂ1 on the factor
binding site. (b) Homology model of Eﬂ1 in its 60S-bound conformation in the
vicinity to eIF6. (Eﬂ1 in red)
from cryo-EM (Spahn et al., 2004), we calculated a comparative model of Eﬂ1 on the
basis of eEF2 in its ribosome-bound conformation. The model of Eﬂ1 was generated,
using the HHpred server (Söding et al., 2005) for sequence alignment. A comparative
model of Eﬂ1 was calculated based on the ribosome-bound eEF2. Parts of the Eﬂ1
sequence which could not be aligned to eEF2, were separately modeled using HHpred.
A ﬁnal model for the 60S subunit-bound Eﬂ1 was calculated using the software package
MODELLER (Sali et al., 1995; Eswar et al., 2007) for model calculation, and MDFF
(Trabuco et al., 2008) for stereochemical adjustments. Strikingly, in this position Eﬂ1p
could bind concomitantly with eIF6 and would perfectly embrace eIF6 to facilitate an
interaction with its GTPase domain (Fig. 11a). The release of eIF6 can in this model
be explained by direct interaction of Eﬂ1 with eIF6. A small conformational change of
Eﬂ1 in this position would be suﬃcient to trigger GTP-dependent release of eIF6 from
the 60S subunit (Fig. 11b).
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5.6. Conclusions
Our structure provides the basis for a molecular understanding of eIF6's conserved ac-
tivity as a ribosomal anti-association factor. Based on our structural data, we propose
a model where the anti-association activity of eIF6 with the mature 60S subunit can be
explained by direct sterical hindrance of the dynamic intersubunit bridge B6 and the
surrounding bridge environment mainly inﬂuencing the bridges B5a and B7. Due to
the intermediate resolution of the cryo-EM map, the accuracy for docking of the eIF6
structure into the assigned density is limited. Conformational changes, which might
occur as a result of the eIF6 interaction with the 60S subunit could not be detected at
this resolution level. Therefore, the reconstruction alone does not allow an unambiguous
assignment of the eIF6 orientation, in terms of binding side and in-plane rotation. In a
previous study, the binding position of archaeal aIF6 with the 50S subunit was shown
biochemically (Benelli et al., 2009). Our cryo-EM map shows the same binding side for
eIF6 as it was identiﬁed for archaeal aIF6. Therefore, the binding site of eIF6 with rpL23
(L14 in archaea) is indeed conserved. In the same study, three RNA residues of helix 69
(H69) located on the 50S intersubunit surface were found as potential binding partner
for archaeal aIF6, by RNA protection experiments. This result is not in agreement with
our structural data, because the binding position of eIF6 found in our cryo-EM map
would not allow for an interaction of eIF6 with these too distant RNA residues.
Outlook
An improved resolution at secondary structure level would allow a docking of eIF6 with
higher accuracy (Rossmann et al., 2005). Certainly, the experimental setup has to be
changed to overcome the orientation problem that is most likely the main reason for the
limited resolution of the 60S-eIF6 reconstruction. Variation of buﬀer conditions (salt,
pH) and glow discharging, or the use of carbon free grids to avoid the inﬂuence of the
charged carbon support layer, which is often inﬂuencing the orientation of particles in
some cases (Frank, 2006), are some possible starting points to come to an improved
dataset with a more homogeneous distribution of the particle orientations.
The recycling of eIF6 is not conserved amongst eukaryotes. In yeast, the GTPase Eﬂ1
acts in concert with the protein Sdo1 to release eIF6 from the 60S subunit. A cryo-EM
structure of a 60S-eIF6-Eﬂ1 complex would be an approach to proof our assumption
of the binding position of Eﬂ1 and its mechanism to release eIF6. Also the role of
Sdo1 in the release of eIF6 has to be established in future studies to come to a better
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understanding of the functions of Eﬂ1 and Sdo1 in the release process. It is known that
eIF6 participates in several pathways, for instance in the recruiting of the RISC complex
and in ribosome biogenesis (Miluzio et al., 2009). Therefore, an interesting target would
be the structural analysis of a 60S eIF6-RISC (TRBP, Dicer, Ago2) complex, which was
characterized in a previous biochemical study (Chendrimada et al., 2007). It remains to
be seen to what extend eIF6's ribosomal binding mode is also functionally involved in
its additional activities in higher eukaryotes. Additional studies are needed to uncover
the relationship between the other various functional activities of eIF6 in vivo (Miluzio
et al., 2009) and its essential anti-association activity.
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6. Folding inside the ribosomal
tunnel
6.1. Speciﬁc aim
We addressed the question if a-helix formation within the ribosomal tunnel is feasible
and if so, where it can occur? In principle would the dimension of the tunnel allow
accommodation of secondary structure elements like a-helices, which can be estimated
from ribosomal X-ray structures (Voss et al., 2006) (see also Fig. 2 in the Introduction).
A number of diﬀerent biochemical studies, including FRET measurements (Woolhead
et al., 2004) and pegylation experiments (Lu & Deutsch, 2005b), point towards the same
direction and gave indirect indications that secondary structure formation can already
occur inside the ribosomal tunnel. However, the question if secondary structure can form
so early in the shielded and non-cytosolic environment of the ribosomal tunnel is still
debated and a solid structural evidence for this problem is missing. We used cryo-EM
and single particle reconstruction to tackle this problem in eukaryotic ribosomes. At
the moment there is no structural access to visualize nascent chains inside the ribosomal
tunnel via crystallography, because 70S ribosome nascent chain complexes (RNCs) could
not be crystallized so far. Furthermore, no X-ray structure of a eukaryotic 80S ribosome
nor of a 60S subunit have been solved. This means that cryo-EM is currently the only
tool that can provide direct structural insights into eukaryotic ribosomal complexes,
like 80S RNCs, with adequate resolution. In addition, our group succeeded already
to visualize diﬀerent nascent polypeptide chains of stalling and non-stalling sequences
inside the ribosomal tunnel with cryo-EM (Seidelt et al., 2009; Becker et al., 2009).
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6.2. Sample preparation
A wheat germ in vitro translation system was utilized to prepare stalled 80S RNCs with
dipeptidyl-aminopeptidase B (DPAP-B) nascent chain in the tunnel (Halic et al., 2004).
DNA templates were truncated and the stop codon was removed, to trap the translating
ribosomes at the last codon. The stalled ribosomal complexes were puriﬁed (Shashi
Bhushan) via His aﬃnity puriﬁcation as described previously (Beckmann et al., 1997)
(for details see 8.2.5 in Materials and Methods).
6.3. Cryo-EM analysis
For this study, two structures of ribosomal complexes bearing nascent chains (RNCs)
with diﬀerent regions of high a-helical propensity were determined. The datasets were
Figure 12.: Resolution curves of the cryo-EM reconstructions (a-c). | Respective
resolution is marked at 0.5 FSC cutoﬀ.
recorded under low-dose conditions on a Tecnai F30 ﬁeld emission gun electron micro-
36
II CHAPTER 6. FOLDING INSIDE THE RIBOSOMAL TUNNEL
scope and scanned on a Heidelberg drum scanner, resulting in a pixel size of 1.24 Å on
object scale. Datasets were further processed with the SPIDER software package (Frank
et al., 1996). After automated particle picking with SIGANTURE (Chen & Grigorieﬀ,
2007) followed by visual inspection 200,000 particles for 80S Helix1-RNC, 230,000 parti-
cles for 80S Helix2-RNC and 250,000 for 80S DPAP-RNC were selected. We sorted the
data into programmed (with P-site tRNA) and un-programmed/empty ribosome (with-
out P-site tRNA) sub-datasets using existing reference reconstructions of programmed
and un-programmed wheat germ 80S ribosomes. Final CTF-corrected reconstructions
had a resolution of 7.1 Å and 7.3 Å for the Helix1 and Helix2 datasets, respectively, and
7.1 Å for the control DPAP dataset, based on the 0.5 FSC cutoﬀ value (Fig. 12a-c).
6.4. Secondary structure marker in the tunnel
In this study, modiﬁed DPAP-B constructs were generated and parts of the sequence
were replaced with a short peptide that has a strong propensity to form a monomeric a-
helix in solution (Marqusee & Baldwin, 1987; Arai et al., 2001) (Fig. 13b). The peptide
contains ﬁve EAAAK repeats and forms a standard [i + 4  i] a-helix, in which every
backbone N-H group donates a hydrogen bond to the backbone C=O group of the amino
acid four residues earlier (Fig. 13b). Each repeat of this helix is stabilized by a Glu−-
Lys+ salt bridge, leading to >80 % helicity in aqueous solvent as determined by circular
dichroism (CD) studies (Marqusee & Baldwin, 1987; Arai et al., 2001). When translation
reaches the 3' end of the truncated mRNA, 115 amino acids have been translated and
Asp-tRNA is located at the P site of the ribosome. The position of the helix sequence
was varied to answer the question where in the tunnel a-helix formation is allowed. In
the Helix1 construct, the helix forming sequence is positioned at amino acids 72-96,
whereas in Helix2, it is located at amino acids 83-108, i.e. -19 and -7 from the Asp of
the P-tRNA, respectively (Fig. 13a). Since the ribosomal tunnel is known to protect
30-40 amino acids (Hardesty & Kramer, 2001), both helix forming sequences should still
be enclosed within the exit tunnel. Since the EAAAK repeats have been structurally
characterized in the antifreeze proteins of cold-water ﬁsh, such as the winter ﬂounder, it
was possible to build a homology model for the helical part of the nascent chain based
on the known crystal structure of the antifreeze protein HPLC6 isoform (Sicheri & Yang,
1995) (Fig. 13b and Fig. 15e).
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Figure 13.: Design of the helix constructs. | (a) An a-helix segment was inserted at
two diﬀerent positions into the DPAP-B sequence. (b) Crystal structure of the
HPLC6 antifreeze protein was taken as basis for the homology model of the
(EAAAK)5 helix (salt-bridges indicated with dashed lines).
6.5. a-helical nascent chains can fold in distinct
tunnel region
In all reconstructions, strong density for a single peptidyl-tRNA within the intersubunit
space is observed (Fig. 14a, c, e). Most striking, however, is the presence of additional
density within the exit tunnel of the 80S Helix-RNCs that can be attributed to the
nascent chain (Fig. 14a-d), whereas in comparison the tunnel of the control 80S DPAP-
38
II CHAPTER 6. FOLDING INSIDE THE RIBOSOMAL TUNNEL
RNC contains little additional density for the corresponding DPAP-B nascent chain (Fig.
14e, f). In the tunnel of the 80S Helix-RNCs, the strongest region of density is observed
Figure 14.: Cryo-EM reconstructions of three 80S RNCs. | Maps of the 80S Helix1-
RNC (a,b), 80S Helix2-RNC (c,d), and the control 80S DPAP-RNC (e,f).
Each top left inset show the respective overall orientation, cross-section and
tunnel view below. Right-hand panels show the cross-section and tunnel view.
for the N-terminal region of the nascent chain near the tunnel exit (Fig. 14a-d).
The densities for the P-tRNA and associated nascent chains of the reconstructions
of the 80S Helix-RNCs and 80S DPAP-RNC were isolated (Fig. 15a-c). A molecular
model for the P-tRNA was ﬁt to the isolated density of the 80S Helix1-RNC (Fig. 15d)
to locate the terminal CCA-end of the tRNA, which thus identiﬁes the C-terminus of
the nascent chain. All three reconstructions have some density corresponding to the
nascent chain directly adjacent to the peptidyl transferase center (PTC) (Fig. 15). In
the 80S Helix1-RNC, the strong density for the N-terminal region of the nascent chain
is consistent with an a-helical conformation in this region and coincides perfectly with
the expected location in the tunnel (Fig. 15d, e). The density can account for four of
the ﬁve EAAAK repeats, correlating to 20 amino acids, or six turns of the a-helix (3.3
amino acids per turn) (Fig. 15e). At lower thresholds, additional density extends into
the solvent from the N-terminal part of the helix, most likely indicating ﬂexibility in this
region. We do not think the a-helix unwinds upon exiting the tunnel, as suggested by
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Figure 15.: Comparison of the tRNA-nascent chains. | Isolated density for the P-
site tRNA and nascent chain from the (a) 80S Helix1-RNC (gold), (b) 80S
Helix2-RNC (blue) and (c) 80S DPAP-RNC (green). (d) transparent density
of (a) with ﬁtted ribbon model for tRNA and nascent chain. (e) Zoom of (d)
with amino acid numbering. (f,g) Zoom of (b) with alternative models for the
Helix2 nascent chain. (CCA - terminal CCA-end)
FRET studies with a transmembrane helix (Woolhead et al., 2004), since the EAAAK
repeats and antifreeze peptides have been shown by CD and NMR to be stable in solution
(Marqusee & Baldwin, 1987; Arai et al., 2001; Liepinsh et al., 2002). With this ﬁtting,
the proximal portion of the helix (Gly97) is located ∼53 Å from the Asp115 amino
acid at the P site, and it is thus only possible to span this distance using an extended
conformation (3.0-3.4 Å/aa) for the 18 interceding amino acids of the nascent chain (Fig.
15e). The properties of the observed density for these regions are also consistent with an
extended conformation for these amino acids, whereas the fragmentation suggests that
the nascent chain does not adopt a distinct conformation in some sections of the tunnel.
Similar to the 80S Helix1-RNC the strongest density for the nascent chain in the 80S
Helix2-RNC is observed in the lower region of the exit tunnel (Fig. 15f). However, if
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all ﬁve repeats of the EAAAK sequence had adopted a helical conformation, we would
have expected strong density to also be present in the middle of the tunnel. Therefore,
it is likely that the proximal portion of the region with helical propensity (residues 97-
108) is unable to adopt an a-helical conformation, but instead acquires an extended
conformation. In this case a model of the distal portion of the remaining helical stretch
(residues 77-97) ﬁts nicely into the strongest region of nascent chain density as an a-helix
(Fig. 15g).
6.6. Contacts of the nascent chain with the
ribosomal tunnel
In order to dissect the contacts between the nascent chain and ribosomal components of
the exit tunnel, a molecular model of the wheat germ ribosomal tunnel (Fig. 16a,b) was
generated and then ﬁt to both the 80S Helix-RNC maps (Fig. 17). In the upper region
Figure 16.: Model of the exit tunnel ﬁtted in 80S Helix1-RNC map. | (a) Exit
tunnel view with cryo-EM density (gray) and rRNA- and protein models. (b)
as in (a), but without map density.
of the tunnel of the 80S Helix1-RNC, three strong connections are observed between
the nascent chain and the tunnel wall (Fig. 17a). Adjacent to the PTC, the nascent
chain appears to form a contact in the vicinity of 28S rRNA nucleotide A2062 (E. coli
numbering used throughout). This contact does not appear to be present in the 80S
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Helix2-RNC (Fig. 17e). From the available ribosome crystal structures, A2062 is known
to be ﬂexible, adopting a position ﬂat against the tunnel wall as in the H. marismortui
apo-50S structure (Ban et al., 2000), or protruding into the tunnel lumen when P-site
tRNA mimics are bound (Schmeing et al., 2005). Clearly, the latter position ﬁts better
to the density of the 80S Helix1-RNC map, suggesting the nascent chain stabilizes a
distinct conformation of A2062 (Fig. 17a). In E. coli, mutations at A2062 relieve the
translational arrest resulting from ErmC stalling (Vazquez-Laslop et al., 2008). Deeper
in the tunnel, the nascent chain establishes contact with A751 in both 80S Helix-RNC
maps (Fig. 17a, e). Insertions at A751 have been reported to eliminate tryptophan-
induction associated with TnaC-mediated translational stalling (Cruz-Vera et al., 2005).
The extensions of ribosomal protein rpL4 form two contacts with the 80S Helix1-RNC
nascent chain, one near the constriction (Fig. 17a) and a second to the proximal end of
the helix (Fig. 17b), whereas in 80S Helix2-RNC the proximal contact is absent (Fig.
17f) and the rpL4 contact at the constriction is signiﬁcantly weaker (Fig. 17e). Between
these two points, negligible density for either nascent chain is observable, indicating
that it does not adopt a single distinct conformation (Fig. 17a, e and g). Despite this,
additional density is observed contacting the tip of the b-hairpin of rpL17 (Fig. 17a). In
E. coli, mutations within this region of L22 (the homologue to rpL17) can relieve TnaC-
and SecM-mediated stalling (Nakatogawa & Ito, 2002; Cruz-Vera et al., 2005). The fact
that the contacts observed here for non-stalling sequences are similar in location to those
predicted for some of the known stalling leader peptides, hints that these regions of the
tunnel represent functional hotspots for tunnel-nascent chain interaction. In both 80S
Helix-RNC maps, the density for the a-helix is sandwiched between ribosomal protein
rpL39 and the loop region of helix 50 (H50) of the 28S rRNA (Fig. 17b, d and f, h).
rpL39 appears to make two strong contacts with the helix, one proximal and the other
more distal (N-terminal), whereas the H50 contact is diﬀerent between the two structures
(Fig. 17b, f).
6.7. Conclusions
Photo-crosslinking studies have identiﬁed sequential contacts of a compacted transmem-
brane containing nascent chain, ﬁrst to rpL4, then rpL17 and ﬁnally to rpL39 (Woolhead
et al., 2004)  ribosomal proteins that are visualized to contact the nascent chain in both
the 80S Helix-RNCs (Fig. 18). In these studies it was concluded that the transmem-
brane helix maintains a helical conformation during its passage throughout the entire
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Figure 17.: Helix-nascent chain interactions. | Cross-section of the upper (top panels)
and lower (bottom panels) tunnel regions of the (a-d) 80S Helix1-RNC (gold),
(e,f) 80S Helix2-RNC (blue) and (g,h) comparison of both. (cryo-EM maps
(gray); isolated density for the nascent chain shown at a lower threshold (gold
and blue mesh); A2062 (E. coli numbering) is shown in two conformations
(a,c), PDB 1S722 (blue) and PDB 1VQN23 (red); contacts between nascent
chain and ribosomal tunnel components indicated with asterisks (*))
ribosomal tunnel. Although we observe no helix formation in the middle of the tunnel,
i.e. directly following the constriction (Fig. 18). The observed discrepancy can be re-
lated to the use of a hydrophobic transmembrane helix (Woolhead et al., 2004), rather
than the hydrophilic helix used here. In any case, the ability to form a helix near to the
tunnel exit site, but not in the middle region of the tunnel, is consistent with the zones
of secondary structure formation identiﬁed by Lu and Deutsch (Lu & Deutsch, 2005b).
Given that a-helix formation within the exit tunnel is indeed possible in distinct
regions, this raises the question as to what the functional signiﬁcance of this ﬁnding is?
First, it is tempting to speculate that allowing, or even promoting (Lu & Deutsch, 2005b),
a-helix formation when b-sheet formation is not yet possible has an impact on protein
folding. This would imply that folding might occur using a hierarchy of secondary
structure elements, with a-helix formation occurring ﬁrst wherever possible. Such a
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Figure 18.: Helix and tertiary structure formation is only observed in the lower
tunnel region. | Schematic representation of a cross-section of the 80S Helix1-
RNC complex.
scenario would considerably reduce the complexity of the theoretical conformational
space that is necessary to be sampled before the correct fold is adopted. Additionally, it
would also change the appearance of nascent peptides as substrates for co-translationally
acting chaperones, e.g. bacterial TF or Hsp70s in eukaryotes (Fig. 19b). Indeed, tertiary
structure formation, such as a- and b-hairpins, has already been observed to occur near
the tunnel exit (>80 Å from tunnel start) where the tunnel widens signiﬁcantly to
form a vestibule (Kosolapov & Deutsch, 2009) (Fig. 18). Second, a-helix formation in
the tunnel may be important for proteins containing alpha-helical domains destined for
membrane insertion. Co-translational targeting by SRP, for example, may be promoted
since a-helicity of the signal sequence is important for its recognition by SRP (Adams
et al., 2002) (Fig. 19b). Indeed, compaction of transmembrane domains in the ribosomal
tunnel has been reported (Woolhead et al., 2004) and, a compacted conformation for
the signal anchor sequence has been observed by cryo-EM to bind in the vestibule at
the end of the ribosomal tunnel on Escherichia coli ribosomes (Halic et al., 2006a).
Third, restricting a-helix formation to only certain regions of the tunnel may reduce
the modes of interaction of the nascent peptide with the tunnel wall. Compared to an
extended chain, a nascent chain forming an a-helix throughout the entire tunnel could
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potentially establish twice as many interactions. This might result in unfavorably stable
interactions. On the other hand, helix formation in permitting regions may help to scan
for distinct interaction patterns facilitating regulatory events. While these hypotheses
Figure 19.: Implications of helix formation within the ribosomal exit tunnel. |
Schematic representation of a cross-section of the 80S Helix1-RNC complex.
The helix of the nascent chain forms interactions with helix 50 (H50, blue)
of the 28S rRNA and rpL39 (magenta). Helix formation in the ribosomal
tunnel may assist in membrane insertion, as shown for signal recognition particle
(SRP) dependent pathway, and/or promote correct or more eﬃcient folding of
cytoplasmic proteins, with or without aid of chaperones, such as Hsp70s.
need to be examined, the universal conservation of the dimensions of the ribosomal
tunnel is consistent with its signiﬁcance in providing nascent proteins with a very deﬁned
ﬁrst environment.
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Outlook
In this study we observed a-helix formation in a deﬁned region of the ribosomal tunnel,
of a hydrophilic segment with high helical propensity. Prospective work can now focus
on the question to what extend natural transmembrane helices can fold in the tunnel.
Of particular interest would be well characterized constructs like the transmembrane
a-helices, which were studied by Hessa et al. in the context of co-translational protein
translocation (Hessa et al., 2005, 2007). The interpretation of the maps is at the current
resolution limit of cryo-EM maps, because it is based on a diﬀerentiation between the
extended part and the a-helical part of the nascent chain. To resolve the complete nascent
chain by cryo-EM is already impressive, but the interpretation stays and falls with the
appearance of the resolved density for the nascent chain, which is not only determined
by the quality of the data (S/N ratio and power spectra). An even bigger inﬂuencing
parameter are the contacts of the nascent chain with the tunnel wall, resulting in stable
or ﬂexible regions for the nascent chain, whereby the latter ones show a loss of density
information (see also in 3.2 Introduction). Thus, it is nearly impossible to distinguish if
an absent or fragmented density in a particular region is the result of ﬂexibility, or of the
inability of the nascent chain to form secondary structure. Interesting and helpful would
be in this case, to validate the ﬁndings based on cryo-EM data with proven biochemical
methods, such as crosslinks, FRET experiments, or pegylation assays, used in Deutsch's
studies (Lu et al., 2007; Lu & Deutsch, 2005b,a). In the long run, crystallization of
70S RNCs would open the possibility to directly address these questions at an atomic
resolution level. To observe as a next step potential b-sheet formation in the ribosomal
tunnel, cryo-EM has to touch atomic resolutions below 4 Å.
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7. Folding beyond the ribosomal
tunnel
7.1. Speciﬁc aim
Most of the current knowledge about chaperone-assisted folding of nascent polypep-
tide chains at the ribosome comes from the well studied bacterial trigger factor (TF).
There are less and exclusively biochemical data of co-translationally acting chaperones
in the complex eukaryotic system available. The aim of this study was to get structural
insights into the ribosome-associated chaperone system and the arrangement of the co-
translational folding machinery at the eukaryotic ribosomal exit tunnel. For this reason,
diﬀerent structural methods were combined. Small angle X-ray scattering (SAXS) was
used to get a ﬁrst low resolution model of RAC in solution. Then cryo-EM in combina-
tion with single-particle reconstruction was used to analyze the interaction of RAC with
the eukaryotic 80S ribosome.
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7.2. Puriﬁcation of RAC
First, high yields of RAC were puriﬁed. In collaboration with the group of Sabine
Rospert in Freiburg a large-scale puriﬁcation protocol was established. RAC is a het-
Figure 20.: RAC puriﬁcation and dynamic light scattering (DLS). | (a) Four step
puriﬁcation protocol of the RAC puriﬁcation, starting with an anion-exchange
column Resource Q, followed by a second anion-exchange column (HQ 20) and
a cation-exchange column (HS 20). (b) The ﬁnal gel ﬁltration run (Superdex
200), leading to a puriﬁed RAC sample. (c) DLS spectra of RAC with a
concentration of 3.4 mg/ml in 100 mM and (d) 200 mM NaCl. The calculated
hydrodynamic radius is indicated in nm. (adapted from Steﬀen Fliehmann)
erologous complex that consists of the two stably interacting proteins, the Hsp70 Ssz
and the J-protein Zuo. Both subunits of the complex diﬀer in their isoelectric point (pI),
which results in a negative and positive net charge for Ssz (pI = 4.8) and Zuo (pI =
8,8) at neutral pH, respectively. The RAC complex was puriﬁed using a combination of
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ion-exchange columns in four chromatography steps (Fig. 20a). First a pre-cleaning step
by an anion-exchange column (Resource Q) was conducted. A second anion-exchange
column (POROS HQ 20) was followed by a cation-exchange column (POROS HS 20),
leading to a homogeneous peak with almost pure fractions with little amount of impu-
rities. The pooled fractions were concentrated and loaded onto a gel ﬁltration column
(Superdex 200) for ﬁnal puriﬁcation, resulting in a highly puriﬁed sample (Fig. 20b)
without impurities. The puriﬁcation protocol of RAC had to be adapted to purify the
deletion mutant RACMZuo110 (complex of the ﬁrst 110 aa of Zuo and Ssz; data not
shown). A three step protocol was used to purify RACMZuo110 using the N-terminal
His6 tag of the truncated subunit Zuo1-110. For the ﬁrst step, an anion-exchange column
(Resource Q) was used followed by a His Trap HP column (Ni-NTA). As in the RAC
protocol, gel ﬁltration chromatography (Superdex 200) was used for the ﬁnal puriﬁcation
step. The two complexes, RAC and RACMZuo110, could be puriﬁed to a high degree
on a large scale. An average puriﬁcation resulted in 0.8 - 1 mg of puriﬁed RAC complex
per 10 g of E. coli cells.
7.2.1. DLS measurements and SAXS model
Based on the puriﬁcation of RAC and RACMZuo110, DLS (dynamic light scattering)
measurements were utilized to analyze the dispersity of the samples. A prerequisite for
SAXS measurements is a pure and monodisperse sample with non-interacting particles
of the same size. For optimal use in SAXS measurements monodisperse properties
should be maintained within a concentration range of 1 to 5 mg/ml. From the measured
DLS curves the hydrodynamic radius of the scattering particles in the sample and the
RSD value, as a measure for the peak distribution, was calculated. An increase of the
hydrodynamic radius of around 1 nm with increasing concentrations of RAC (1 and 3
mg/ml) was observed, indicating that the molecules of the sample tend to form higher
order aggregates (data not shown). The salt concentration was increased to reduce
potential intermolecular interactions between RAC molecules in the sample, to lower the
formation of aggregates. The best result could be achieved when the NaCl concentration
was increased from 100 mM to 200 mM, resulting in a more deﬁned peak with constant
hydrodynamic radius, coupled with a shift towards a smaller RSD value (30 % to 18
%) (Fig. 20c, d), indicating that less aggregates were formed and more monodisperse
particles of RAC were present. The same eﬀect in the DLS measurements was observed
for RACMZuo110, thus the SAXS measurements were utilized in 200 mM NaCl.
SAXS is a structural method that can provide low resolution information about the
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shape of a complex in solution. The SAXS measurements were accomplished at the
DESY in Hamburg using a concentration of 2.2 mg/ml and 3.4 mg/ml for RAC and the
RACMZuo110 mutant, respectively. The calculated model reveals an elongated complex
Figure 21.: SAXS model of RAC. | Initial models of (a) wild-type RAC and (b)
RACMZuo110. (c) Ssz homology model ﬁtted into the RAC model of (a).
The gray box indicates the assigned position of Ssz. (d) Two reﬁned RAC
models were superimposed in their Ssz part, showing large conformational dif-
ferences in the assigned Zuotin part. (e) RAC has an overall length of around
200 Å (ﬁtted Ssz homology model in red). (adapted from Christoph Leidig)
for RAC, whereby the main length is provided by the Zuotin part (Fig. 21a). By
comparison of the two models of wild-type RAC (Fig. 21a) and RACMZuo110 (Fig.
21b), the Zuotin part of RAC could be assigned in the SAXS model of RAC (Fig.
21c). A homology model of Ssz based on the X-ray structure of bovine Hsc70 (PDB
1YUW) was ﬁtted into the assigned Ssz part of the RAC SAXS model, which also
validates the assignment of the Ssz and the Zuotin part (Fig. 21c). The fact that the
experimental scattering curve can be interpreted by several models, results in a Zuotin
50
II CHAPTER 7. FOLDING BEYOND THE RIBOSOMAL TUNNEL
part of RAC that shows ﬂexibility and which can adopt diﬀerent conformations (Fig.
21d). In contrast, the Ssz part appears to have a lower degree of ﬂexibility (Fig. 21d).
Due to the limited resolution of the SAXS structures the location of some interesting
elements, like the charged region as a putative ribosomal binding site and the J-domain,
can not be predicted. The low resolution SAXS model of RAC provided a ﬁrst structural
information of the complex in solution. However, to investigate the ribosome interaction
of RAC, cryo-EM analysis of reconstituted 80S RAC complexes was realized.
7.3. Reconstitution experiments
A prerequisite for structural analysis with cryo-EM is a deﬁned and homogeneous sam-
ple. Therefore, the complex of interest has to be reconstituted in vitro. Binding assays
were utilized to ﬁnd optimal conditions to reconstitute the 80S RAC and the 80S RAC-
Ssb1 RNC complex. Using this assay the binding of ribosome-associated factors was
characterized indirectly by co-pelleting the factor with ribosomes through a sucrose
cushion. The binding was studied under low and high salt conditions, meaning in this
case 100 mM and 500 mM KOAc, respectively. Yeast 80S ribosomes were isolated from
a DRACDNACDSsb knock out strain Dzuo1Dssz1Dedg1Dedg2Dssb1Dssb2
(80SDDD, IDA123456A - Rospert group) as described in Materials and Methods. A
self-made in vitro translation system (Walter et al., 1981) was utilized to purify yeast
80S RNCs via His tag puriﬁcation (for details see 8.2.5 in Materials and Methods).
RNC complexes with nascent chains based on the sequence of Dipeptidyl aminopepti-
dase from yeast (DPAP) were puriﬁed as previously described (Beckmann et al., 1997).
Truncated mRNA without a stop codon was used to stall the translation reaction at
the last codon, leading to artiﬁcially stalled 80S RNCs with P-site tRNA bound to the
nascent polypeptide chain. Wheat germ RNCs were puriﬁed by using a commercial or a
self-made in vitro translation system. Mammalian RAC and Ssb1 were used as puriﬁed
components (Rospert group) for the reconstitution experiments. RAC was puriﬁed with
the described large-scale puriﬁcation protocol.
First, the binding of mRAC to 80S DPAP-RNCs from wheat germ (wg80S ) was
analyzed. From previous studies it is known that some heterologous complexes with
wheat germ 80S ribosomes (wg80S) turned out to be a stable combination and thus
perfect for cryo-EM. Successful examples are the structures of wheat germ 80S RNCs
with mammalian SRP (Halic et al., 2004) and with the mammalian Sec61 complex
(Becker et al., 2009), where artiﬁcially stable complexes with the wheat germ ribosome
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could be formed. A stoichiometric binding of mRAC to wheat germ 80S RNCs was
detected in the SDS gel of the reconstitution experiment indicated by two bands of
mRAC (MPP11 and Hsp70L1) in the pellet fraction, having the same range of intensity
as the ribosomal bands (Fig. 22). The experiment showed also a comparable binding of
mRAC to 80S DPAP90-RNCs and to 80S DPAP120-RNCs (Fig. 22). The data indicate
Figure 22.: Reconstitution of a wheat germ 80S DPAP-RNC mRAC complex (80S RNC
mRAC complex) using 100 mM KOAc. (P - pellet; S - supernatant)
the formation of a high aﬃnity 80S RNC mRAC complex under low salt conditions of
100 mM KOAc without a clear discrimination of the length of the nascent chain.
Most of the biochemical informations about eukaryotic ribosome-associated chaper-
ones comes from the well studied chaperone triad of yeast. RAC binds independently
of the presence of nascent chains to un-programmed yeast 80S ribosomes (y80S ) (Fig.
23a) under low salt conditions of 100 mM KOAc, which is consistent with previous bio-
chemical data (Raue et al., 2007). The amount of 80S-bound RAC remained constant
over the tested molar range of 20 to 100 times molar excess of RAC over 80S ribosomes
(Fig. 23a). The binding of RAC to yeast 80S ribosomes can be saturated, indicating a
speciﬁc interaction with the ribosome (Fig. 23a). It is apparent that RAC binds substo-
ichiometrically to 80S ribosomes which is true for low salt conditions (Fig. 23a), whereas
the binding was drastically reduced and nearly not detectable under high salt conditions
of 500 mM KOAc in reconstitution assays (data not shown). This is in agreement with
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recent data, showing that the interaction of RAC is salt sensitive and that ∼50 % of
bound RAC is already released at 340 mM KOAc (Peisker et al., 2008). The 80S-RAC
interaction is highly destabilized with increasing salt concentrations showing that the
binding is most likely mediated by electrostatic interactions. The binding of RAC to 80S
DPAP90-RNCs is also substoichiometric (Fig. 23b), which is in agreement with the fact
that RAC does not interact with the nascent chain and shows therefore a similar binding
as observed for the un-programmed 80S-RAC interaction (Fig. 23a). Consistent with
previously published in vivo data (Raue et al., 2007), Ssb1 can bind alone to 80S RNCs
even when RAC is not present (Fig. 23b). Since Ssb1 is known to be the only active
Hsp70 of the chaperone triad showing ATPase activity, AMPPNP (non-hydrolyzable
ATP analog) and ADP was added to the reaction. No diﬀerence in the binding of RAC
and Ssb1 to 80S RNCs could be detected when AMPPNP or ADP was added (Fig. 23b)
and the interaction was still substoichiometric and remained on a similar level as it was
observed for the 80S-RAC interaction (Fig. 23a). Thus, the Ssb1 binding to RNCs was
Figure 23.: Reconstitution of yeast 80S RAC complexes. | (a) RAC binding to un-
programmed 80S ribosomes can be saturated. (b) Reconstitution of the 80S
DPAP-RNC RAC and - RAC-Ssb1 complex from yeast. (low salt conditions -
100 mM KOAc; P - pellet; S - supernatant)
not inﬂuenced by the nucleotide state in this assay. It has been shown that the RNC-
Ssb1 interaction is not aﬀected by ATP, which normally destabilizes the Hsp70-substrate
interaction, suggesting a direct association of Ssb1 with the ribosome independent of the
nascent chain (Pfund et al., 1998). Compared to the substoichiometric binding of RAC
to yeast 80S the interaction of mRAC with 80S RNCs appeared to be stoichiometric in
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the reconstitution experiments, most likely due to the higher aﬃnity of the mRAC bind-
ing. Both, the yeast and the wheat germ RNC-RAC samples could be characterized as
good cryo-EM samples and structures of the reconstituted complexes were determined.
7.3.1. 80S ribosomes with rpL25-Ssb1 fusion (80S-Ssb1)
The aim of this approach was to stabilize the transiently acting Ssb1-RAC ensemble at
the ribosome by a permanent presence of one of the binding partners. For that reason,
the Hsp70 chaperone Ssb1 was fused via a ﬂexible peptide linker to the ribosomal protein
rpL25 (Fig. 24c). The increased local concentration of Ssb1 at the ribosomal exit tunnel
Figure 24.: Generation of modiﬁed 80S ribosomes with rpL25-Ssb1 fusion. | (a)
The haploid yeast strain BY_L25-SSB1 (Drpl25 pRS315-L25-SSB1) was gen-
erated and tested under selective growth conditions. (b) Ssb1 can be cleaved
from yeast 80S-Ssb1 ribosomes under high salt conditions. (c) Design of the
rpL25-Ssb1 fusion construct. (P - pellet and S - supernatant; G418 = 420
µg/ml G418; L - 15 aa ﬂexible peptide linker; P - Prescission protease cleav-
age site; 80SDDD - 80S ribosomes of the DRACDNACDSsb knock out strain
IDA123456A)
could potentially increase the binding of Ssb1 to the nascent chain, to the ribosome
itself and to its J-protein binding partners Zuotin. It is known from previous studies
that rpL25 can be modiﬁed at its C-terminus and fused with GFP, which was used
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as a reporter construct to study 60S nuclear export (Hurt et al., 1999; Dalley et al.,
2008). Yeast cells were genetically modiﬁed to generate 80S ribosomes with a fusion of
Ssb1 to the C-terminus of the ribosomal exit tunnel protein rpL25. Based on a diploid
yeast strain with only one copy of RPL25 (BY4743, RPL25::kanMX4/rpl25), the haploid
fusion strain BY_L25-SSB1 (Drpl25 pRS315-L25-SSB1) was generated by sporulation,
tetrad dissection and selective growth conditions (for details see Materials and Methods).
The yeast strain BY_L25-SSB1 was veriﬁed under three conditions of selective growth.
The cells did not grow on URA deﬁcient media, showing that the BY_L25-SSB1 cells
replaced their pRS316-L25(CEN, URA3) plasmid during FOA selective growth (Fig.
24a). But the cells grew on LEU deﬁcient plates and on plates with the eukaryotic
antibiotic kanamycin (G418) (Fig. 24a), meaning that the cells have a pRS315-L25-
SSB1(CEN, LEU2) plasmid and a kanamycin resistance cassette. The modiﬁed yeast
80S ribosomes with fused Ssb1 (80S-Ssb1) were isolated from the yeast strain BY_L25-
SSB1 (see Materials and Methods) and analyzed by SDS-PAGE. The isolated ribosomes
showed a shift of the rpL25 band to a molecular weight of around 80 kDa, which is the
expected molecular weight of the rpL25-Ssb1 fusion protein with around 82 kDa (Fig.
24b). The rpL25-Ssb1 fusion was also veriﬁed by western blot analysis against rpL25
(data not shown). Furthermore, the fusion with rpL25 could be cleaved speciﬁcally by
adding Prescission protease and Ssb1 remained in the supernatant fraction under high
salt conditions of 500 mM KOAc, showing that the inserted protease cleavage site can
be used for the selective cleavage of the fused Ssb1 (Fig. 24b). The rpl25-Ssb1 fusion
has shown that the cells are viable and the generated haploid strain BY_L25 (Drpl25
pRS316-L25) can be used as a platform for a fusion of other exit tunnel ligands, like
Zuotin or Ssz to rpL25. The modiﬁed 80S-Ssb1 ribosomes of the strain BY_L25-SSB1
were analyzed by cryo-EM.
.
7.4. Cryo-EM analysis
Structures of 80S RAC complexes from diﬀerent organisms were reconstructed by means
of cryo-EM and single particle analysis to get structural insights into the interaction of
RAC with the 80S ribosome. The datasets were either recorded on a Tecnai F30 cryo-
microscope at 300 kV or on a Tecnai Spirit G12 cryo-microscope at 120 kV under low-dose
conditions. All densities were isolated using binary masks and the datasets were pro-
cessed with the SPIDER software package (Frank et al., 1996). After automated particle
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picking with SIGNATURE (Chen & Grigorieﬀ, 2007) followed by visual inspection with
WEB (Frank et al., 1996) 59,000 particles were selected for the wg80S RNC mRAC
dataset. The dataset was sorted for the presence of P-site tRNA (P-tRNA) and the ﬁ-
nal CTF-corrected reconstructions had a resolution of around 15 Å (for details see 9.3.1
in Materials and Methods). The map of the wg80S RNC mRAC complex shows the
typical appearance of a programmed wheat germ 80S ribosome with a clear density for
the P-tRNA in the intersubunit space (Fig. 25a). However, the cryo-EM reconstruction
Figure 25.: Cryo-EM map of wg80S RNC mRAC complex. | The map was ﬁltered
at 18 Å and is shown at (a) high contour level and (b) at low contour level.
(ES27 - part of the rRNA expansion segment 27; position of the exit tunnel is
indicated by asterisks (*))
shows no clear additional density for the ligand mRAC in the exit tunnel region (Fig.
25a). At low contour level fragmented density for mRAC appears near the exit tunnel,
which could not be interpreted further (Fig. 25b). The fragmented appearance of the
density indicates a ﬂexible binding of mRAC to the 80S ribosome, leading to a loss of
density information.
Eukaryotic ribosome-associated chaperones are best characterized for S. cerevisiae.
For that reason the 80S DPAP120-RNC RAC-Ssb1 complex from yeast (80S RNC RAC-
Ssb1 complex) was reconstructed. In yeast 80S ribosomes the characteristic and dynamic
rRNA expansion segment ES27 forms a 150 Å long rRNA helix that is stabilized in
two distinct conformations (Beckmann et al., 2001). In its L1 conformation (ES27-
L1) the rRNA arm of ES27 is directed towards the ribosomal protein rpL1 and ES27
does not interfere with the exit site (Fig. 26a). In the ES27-exit conformation the
RNA arm is rotated 90° counter clockwise and positioned over the exit site (Fig. 26b).
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Figure 26.: ES27 conformations in yeast. | Maps of 80S RNCs with ES27 in its L1
conformation (a) and in its exit conformation (b). The tip of ES27 is indicated
by an arrowhead. (ES27-L1 and ES27-E - L1- and exit conformation of ES27,
respectively; tunnel position indicated by asterisk (*))
Thus, in its exit conformation ES27 interferes with ligands that bind in the exit tunnel
region, such as RAC or Sec61. Around 50,000 particles of the 80S RNC RAC-Ssb1
dataset were selected and it was sorted in two steps. First the data were classiﬁed for
ES27 conformations, resulting in 34,000 particles with ribosomes having the ES27-L1
conformation and 16,000 particles remained for the ES27-exit conformation. The sub-
dataset with ES27-L1 conformation was further sorted for the presence of RAC density,
resulting in 18,000 particles with additional RAC density and 16,000 particles without
a ligand density, respectively. The classiﬁed reconstruction of the 80S RNC RAC-Ssb1
dataset shows a programmed yeast 80S ribosome with density for ES27 in its L1 position
(Fig. 27a). Strikingly, the reconstruction revealed a clear additional density near the
exit tunnel (Fig. 27a). This extra density can be assigned to the 80S-bound RAC. The
density is directly connected to the known interaction partner of RAC, the ribosomal
protein rpL31 (C1) (Peisker et al., 2008). Peisker et al. showed that RAC is anchored to
the ribosome via a second binding partner, which they expected to be RNA. Consistent
with these ﬁndings a second binding site (C2) is resolved in the map (Fig. 27b) that can
be assigned to helix H59 of the 28S rRNA (Fig. 28). It is clear that the observed density
can only comprise the direct 80S-bound part of RAC (Fig. 28). First, the density is
signiﬁcantly smaller than the low resolution SAXS model of RAC and only a part of
the SAXS model ﬁts into the density (Fig. 29). Second, the density is not large enough
to comprise the molecular mass of RAC with 110 kDa. Third, a density for Ssz is not
resolved in the map, which is in agreement with the SAXS model of RAC showing a
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Figure 27.: Cryo-EM reconstruction of the 80S RNC RAC-Ssb1 complex. | (a)
Side view of the map with extra density for RAC at the exit tunnel region.
Close-up view of the RAC density, ﬁltered (b) at 29 Å and (c) at 16.5 Å using
a low-pass gauss ﬁlter. (ES27 - L1 conformation of ES27; C1/C2 - two binding
sites of RAC with the 60S)
broad spectra of conformations in the Zuotin part (Fig. 29) by which RAC is anchored
to the ribosome (Gautschi et al., 2001).
Figure 28.: RAC binding site at the 80S ribosome. | RAC binds to rpL31 and to the
rRNA helix H59. (a) Top view of the isolated RAC density and density shown
as mesh. (b) Side view, showing the interaction partners. Thumbnails show
the overall orientation. (RAC - orange; 60S - gray mesh; rpL31 - magenta; H59
- green)
Therefore, the resolved density can be assigned to be part of Zuotin that is bound
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to the ribosome via the binding partners rpL31 (C1) and the RNA helix H59 (C2).
However, the main binding site of RAC seems to be formed by the contact C1 (rpL31).
The connection to the second binding partner helix H59 (C2) is lost when the map is
ﬁltered at higher spatial frequency, meaning that details up to 16.5 Å are still resolved
in the map (Fig. 27c). In addition, the entire RAC density appears more fragmented
at 16,5 Å (Fig. 27c) when more high frequency information is present, compared to the
low resolution map having only details up to 29 Å present (Fig. 27b).
Figure 29.: Two SAXS models of RAC ﬁtted into the cryo-EM map. | (a) and
(b) The 80S RNC RAC-Ssb1 complex with SAXS models docked into the RAC
density. The SAXS models are the same as in Fig. 21c. RAC density is shown
as orange mesh. (60S - gray, 40S - yellow, RAC models - blue and green)
The tendency of the RAC density to fragment at higher resolution indicates a ﬂexible
interaction of RAC with the 80S ribosome. Consistent with the assumption that a
ﬂexible interaction is the reason for a loss of density information, no extra density for
the second ligand Ssb1 is resolved in the map of the 80S RNC RAC-Ssb1 complex. The
Hsp70 chaperone Ssb1 is thus not stabilized upon ribosome binding leading to a loss of
density information for the ﬂexibly bound Ssb1.
The 80S-Ssb1 RAC dataset was determined on a Tecnai Spirit G12 cryo-microscope.
After automated particle picking and visual inspection around 14,000 particles were
selected for the 80S-Ssb1 RAC dataset. The data were classiﬁed for the two distinct
ES27 conformations. After sorting around 3,100 particles remained for the ES27-exit
conformation and 10,700 particles were sorted out with ES27-L1 conformation. The
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previously described 80S ribosomes with the rpL25-Ssb1 fusion (80S-Ssb1; see also 7.3.1)
were used to reconstitute the 80S-Ssb1 RAC complex. The structure of the 80S-Ssb1
Figure 30.: Cryo-EM reconstruction of the 80S-Ssb1 RAC complex. | (a) Side
view of the map with additional densities at the exit region. Close-up view of
the exit site of the same map, ﬁltered at 22 Å (b), and ﬁltered at 19.5 Å (c)
using a low-pass gauss ﬁlter. Thumbnails show the overall orientation. (ES27 -
L1 conformation of ES27; C1/C2 - additional contacts, with nearest ribosomal
component in brackets; position of the exit tunnel is indicated by asterisks (*))
RAC complex with a resolution of around 20 Å revealed a yeast 80S ribosome with an
additional density at the exit site (Fig. 30a). After sorting of the dataset against the
two distinct conformations of ES27, the resulting map shows a clear density of ES27
in its L1 conformation (Fig. 30a). Therefore, it can be excluded that the additional
density is part of ES27 and the extra density can be identiﬁed as the fused Ssb1 (Fig.
30a). Furthermore, the position of the observed extra density is near the expected
region of rpL25 to which Ssb1 was linked. The density of the fused Ssb1 appears more
fragmented when the map is ﬁltered at a spatial frequency that corresponds to 22 Å in
real space (Fig. 30b), compared to the result when the map is ﬁltered at 19.5 Å (Fig.
30c). Even though the linked Ssb1 is permanent present at the ribosomal exit tunnel
it is not stabilized in a deﬁned conformation, indicating a ﬂexible interaction of Ssb1
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with the ribosome. In addition, two extra densities are resolved in the map, marked as
contacts C1 and C2 (Fig. 30b). The extra density contact C1 is located in the vicinity
of rpL31. It is tempting to speculate that C1 is part of RAC, since the position of
C1 is in good agreement with the RAC crosslink to rpL31 (Peisker et al., 2008). The
second contact C2 is of unknown origin and it is positioned near the rRNA helix H7
(H7) and the ribosomal protein rpL26. Due to the intermediate resolution of the map
only a preliminary interpretation of the additional densities can be done and no further
information for RAC is resolved in the reconstruction.
7.5. Conclusions
In this study, the established puriﬁcation protocol for RAC and the mutant RACMZuo110
was used to generate a pure and well deﬁned sample suitable for SAXS analysis. The
low resolution SAXS model of RAC revealed an elongated complex with conformational
ﬂexibility in its Zuotin part. The cryo-EM reconstruction of the 80S RNC RAC-Ssb1
complex showed that RAC binds indeed via a mixed RNA-protein interaction to the
yeast 80S ribosome involving the two binding partners rpL31 and the rRNA helix H59
of the ribosomal exit tunnel. This result is in agreement with previously published data,
where a crosslink to rpL31 and the involvement of RNA has been described (Peisker
et al., 2008). In the same study it has been shown that the 80S binding of RAC is highly
salt sensitive (Peisker et al., 2008). Therefore, the binding site of RAC which is formed
by rpL31 and H59 is most likely mediated by electrostatic interactions. RAC does not
physically interact with nascent chains but it prefers to bind to translating ribosomes
(Raue et al., 2007) most likely due to the increased presence of the co-chaperone partner
Ssb. In the reconstitution experiments a substoichiometric binding of RAC to yeast
80S and to RNCs was found (Fig. 22a and 23), which is typical for a low aﬃnity in-
teraction. Depending on the degree of ﬂexibility the ﬂexible part becomes fragmented
or even invisible in a cryo-EM reconstruction as s result of conformational averaging
(Penczek et al., 2006), due to a loss of information (see also 3.2 in Introduction). Besides
ﬂexibility the observed low aﬃnity binding of RAC and Ssb1 to the ribosome will result
in a substoichiometric occupancy. Below a certain threshold of occupancy (around 30
%), the aﬀected ligand density appears also as fragmented density or it is invisible as
a result of loss of information (Penczek et al., 2006). In the case of the interaction of
RAC and Ssb with the ribosome both, ﬂexibility and low occupancy contribute to a loss
of density information but most likely the inﬂuence of ﬂexibility is higher. Consistent
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with this assumption, the binding assay of the heterologous wg80S RNC mRAC com-
plex showed a stoichiometric binding of mRAC to the RNCs (Fig. 22b), however, the
cryo-EM map of the complex revealed only fragmented densities at low contour levels at
the exit site. A distinct additional density for the fused Ssb1 could be observed in the
map of the 80S-Ssb1 RAC complex, but the density appeared fragmented when more
high frequency information corresponding to high resolution details were present as a
result of ﬁltering (Fig. 30c). This result also indicates a ﬂexible interaction of Ssb1 to
the yeast ribosome and to RAC. A high degree of ﬂexibility in the ribosome binding
of the RAC-Ssb1 ensemble is also conﬁrmed by the fact that no solid extra density of
RAC is resolved in the 80S-Ssb1 RAC structure. It is known that the binding of Ssb
to un-programmed ribosomes is salt sensitive but stabilized through the presence of the
nascent chain (Pfund et al., 1998). It has been shown that Ssb prefers to bind to RNCs
with PGK (Phosphoglycerate kinase) as nascent chain (Raue et al., 2007). But also the
reconstruction of a 80S PGK-RNC RAC-Ssb1 complex (data not shown) showed not an
interpretable density for one of the ligands, indicating that the binding of RAC and Ssb1
was not signiﬁcantly stabilized by the presence of a cytosolic nascent chain. This ﬁnding
is supported by data that show that Ssb seems to be an unusual and fungal-speciﬁc
Hsp70 with unspeciﬁc substrate spectra, showing no peptide binding activity to typical
Hsp70 substrates in vitro (Pfund et al., 2001). Taken together, RAC is an elongated and
ﬂexible complex that interacts transiently and with low aﬃnity with the 80S ribosome
and with its co-chaperone partner Ssb.
A dynamic interplay: RAC and Ssb form a functional folding unit
at the exit tunnel
The key question is, how the eukaryotic chaperone system at the exit tunnel is spatially
and temporally organized, and how is it regulated? Four players act together in yeast,
namely RAC, Ssb, the 80S ribosome and the nascent chain. The elongated shape of
RAC in combination with its ﬂexibly bound Zuotin part would allow a large operation
radius for the complex around the ribosomal exit tunnel, indicated by an arrow in
Fig. 31a and b. The working horse of the chaperone system is Ssb, which is mainly
modulated by the presence of RAC and the nascent chain. Compared to the more
simple situation in prokaryotes the eukaryotic system is even more complicated, due to
the presence of the dynamic rRNA expansion segment ES27 in eukaryotic ribosomes,
which sterically interferes with the ribosomal exit site (Fig. 26b). In this context it is
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highly interesting to ask, if ES27's conformational states can act as a coordinator for
ligands of the exit site in yeast, either indirectly by a pure sterical regulation or directly
by an interaction with ligands, like RAC, Ssb or NAC (Fig. 26b)? These questions might
only be clariﬁed by a combination of diﬀerent methods and better resolution, including
a crystal structure of RAC, that is needed for a molecular interpretation of the cryo-
EM data. As demonstrated in this work, the ribosome-associated chaperone system of
Figure 31.: A functional folding unit at the tunnel exit. | The dynamic interplay of
RAC and Ssb at the exit tunnel might be regulated by ES27 conformations. (a)
Model of the ribosome-associated chaperone triad in yeast with ES27 in its L1-
and (b) in its exit conformation (ES27-E). (H59 - helix 59; tunnel indicated by
asterisk(*))
yeast acts in a dynamic interplay, whereby the folding is realized for a broad spectra of
nascent chains by a cooperative action of Ssb and RAC that form a functional folding
unit (Fig. 31), which might be regulated by ES27's conformational states and via the
competitive binding side rpL31, that is shared with the other nascent chain binder NAC
(unpublished data of B. Beatrix).
The only structural informations about the function of ribosome-associated chaperones
arise from 50S crystal structures with the bound TF binding domain (Schlünzen et al.,
2005; Ferbitz et al., 2004). The current model of Ban and coworkers (Kramer et al., 2009)
for the bacterial system, also called 'concerted model' (Giglione et al., 2009), proposes
a concerted action of TF and PDF (peptide deformylase) at the tunnel exit, based
on the concomitant positioning of the factors, which was concluded from co-crystal
structures (Ferbitz et al., 2004; Bingel-Erlenmeyer et al., 2008). In this model the
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emerging nascent chain interacts ﬁrst with TF, which is supposed to form a hydrophobic
'cradle' (Ferbitz et al., 2004) that serves as a shielded folding environment beneath the
exit tunnel and that passively routes the chain for ﬁrst co-translational modiﬁcations to
PDF and afterwards to MAP (methionine aminopeptidase). In contrast to the 'concerted
model' (Giglione et al., 2009) proposed for the prokaryotic RPBs, our data suggest a more
dynamic view rather than a hierarchical sequence of the actions at the eukaryotic exit
tunnel, which was also discussed by other publications (Yonath, 2006; Kaiser et al.,
2006; Giglione et al., 2009). The concerted mechanism of the bacterial system is based
on static ribosomal X-ray structures without a nascent chain, where only a small and
most stable part of the dynamic ligand is present (Ferbitz et al., 2004; Bingel-Erlenmeyer
et al., 2008), whereas cryo-EM reconstructions are based on native complexes.
Outlook
The main challenge for future work is to deal with the intrinsic ﬂexibility of the sys-
tem. Basically there are two approaches, either by biochemical methods or by the use
of sophisticated sorting methods that handle the problem on data processing level. An
unsupervised classiﬁcation method called 'focused classiﬁcation' (see also 3.2 of the In-
troduction) uses 3D variance analysis as basis for the sorting of heterogeneous datasets
(Penczek et al., 2006). With this unsupervised classiﬁcation method it might be possible
to sort out diﬀerent conformations of 80S-bound RAC and Ssb1 based on a high quality
dataset with good contrast. The rpL25 fusion approach can be extended to generate
modiﬁed 80S ribosomes fused with Zuotin that should result in a permanent presence of
RAC at the ribosomal exit site and which might have the potential to open the door to
visualize the complete RAC-Ssb triad at the ribosome by cryo-EM. As demonstrated in
this study, a comprehensive view of this ﬂexible system can only be reached if diﬀerent
methods will be combined. It can be tried to record SAXS data of a 80S RAC com-
plex. Recently published SAXS methods can provide low resolution models of ﬂexible
complexes and even transiently present species in solution (Blobel et al., 2009). SAXS
is also not limited by the size of the observed ensemble, which has already been demon-
strated for ribosomal SAXS models (Svergun et al., 1997). Biochemical methods can be
used to analyze the exact binding environment of RAC at the 80S ribosome for instance
by crosslinking experiments coupled with sophisticated mass spectrometry, aiming to
identify the involved residues or by site directed mutagenesis, which requires profound
structural informations of the binding interface.
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8. Biochemical experiments
8.1. Molecular cloning
8.1.1. Polymerase chain reaction (PCR)
Primer were designed by the programs and the Oligo Properties Calculator
(http://www.basic.northwestern.edu/biotools/oligocalc.html) and odered at Metabion
(Munich).
PCR was used to amplify DNA from a template, either for cloning or as template
for in vitro transcription reaction. 100 µl reactions, comprising 10 µM of forward and
reverse primer, 5-80 ng template DNA, 2 U DNA polymerase, 10µl 10x reaction buﬀer
with dNTPs and 2-3 mM MgCl2 or the kit Phusion Flash High-Fidelity Master Mix®
(Finnzymes) was used as 20 µl reaction, where only to 10µl of the 2x Master Mix,
primers and template DNA was added, according to the manufacturer's protocol. In
some cases, 100 µl reaction based on the kit EasyStart PCR Mix-in-a-Tube® (Molecular
Bioproducts) were used. Reactions were conducted using appropriate cycling programs.
Samples were analyzed subsequently by agarose gel electrophoresis.
8.1.2. In vitro transcription
Capped mRNA as template for in vitro translation reactions, used in the RNC puriﬁ-
cation, was generated by in vitro transcription reaction. The reaction was based on
a kit (mMessage mMachine® kit, Ambion) and used according to the manufacturer's
protocol, to get high yields of capped mRNA, which is needed for an eﬃcient in vitro
translation reaction. In a typical 20 µl reaction 1 µg template DNA was used, the reac-
tion was incubated overnight at 37°C and precipitated by adding 30 µl LiCl solution and
ddH2O (part of kit) per 20 µl reaction. After incubation for 2 h at -20°C, reactions were
centrifuged, washed with 70 % ethanol, the dried pellets were resuspended in nuclease
free water and the concentration was determined by measuring the absorption at 260
nm.
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name composition
100K-BA buﬀer 20 mM Tris/HCl pH 7.0, 100 mM sucrose, 100 mM KOAc, 7.5 mM Mg(OAc)2, 2 mM DTT,
1 % PIP (complete protease inhibitor pill (Roche)), 10 µg/ml cycloheximide
1 M sucrose cushion 50 mM Tris/HCl pH 7.0, 25 mM Mg(OAc)2, 5 mM b-mercaptoethanol, 1 M sucrose, 10
µg/ml cycloheximide, 0.1 % Nikkol, 0.1 % PIP, 100 mM (low salt) or 500 mM (high salt)
KOAc
750 mM sucrose
cushion
20 mM Tris/HCl pH 7.0, 750 mM sucrose, 100 mM KOAc, 7.5 mM Mg(OAc)2, 2 mM DTT,
1 % PIP, 10 µg/ml cycloheximide
250 buﬀer 50 mM Tris/HCl pH 7.0, 250 mM KOAc, 25 mM Mg(OAc)2, 5 mM b-mercaptoethanol, 250
mM sucrose, 10 µg/ml cycloheximide, 0.1 % Nikkol, 0.1 % PIP, 10 units/ml anti-RNAsin
(Ambion)
250/100 buﬀer (250 buﬀer with 100 mM Imidazole); 250/tRNA buﬀer (250 buﬀer with 10
µg/ml tRNA)
500 buﬀer 50 mM Tris/HCl pH 7.0, 500 mM KOAc, 25 mM Mg(OAc)2, 5 mM b-mercaptoethanol, 250
mM sucrose, 10 mg/ml cycloheximide, 0.1 % Nikkol, 0.1 % PIP
grid buﬀer 20 mM Tris/HCl pH 7.0, 50 mM KOAc, 2,5 mM Mg(OAc)2, 1 mM DTT, 125 mM sucrose,
100 µg/ml cycloheximide, 0.05 % Nikkol, 0.5 % PIP
12,5 x E-Mix (energy
providing)
12.5 mM ATP, 6.25 mM GTP, 250 mM creatine phosphate, 1.25 mg/ml creatine phosphate
kinase, 1.25 mg/ml tRNA
25 x CB
(compensation buﬀer)
332.5 mM HEPES, 2.9 M KOAc, 45.8 mM Mg(OAc)2, 32.5 mM DTT
YPD/Sorbitol 1 M sorbitol in YPD (20 g peptone + 10 g yeast extract + 20 g glucose in 1 L)
buﬀer PD 100 mM TRIS pH 8,0, 10 mM DTT
YTE-lysis buﬀer 20 mM Hepes pH 7.5, 100 mM KOAc, 7.5 mM Mg(OAc)2, 1 mM DTT, 0.5 mM PMSF
1.5 or 2 M 80S-sucrose
cushion
20 mM Hepes pH 7.4, 7.5 mM Mg(OAc)2, 500 mM KOAc, 1.5 or 2 M sucrose, 1mM DTT,
1mM PMSF, 0.1 % PIP
80S-lysis buﬀer 20 mM Hepes pH 7.4, 7.5 mM Mg(OAc)2, 100 mM KOAc, 1mM DTT, 1 mM PMSF
buﬀer A 20 mM Hepes pH 7.0, 100 mM KCl, 2,5 mM Mg(OAc)2, 1 mM DTT
RAC-lysis buﬀer 40 mM Hepes/KOH pH 7.4, 240 mM KOAc, 0.014 % (v/v) b-mercaptoethanol, 1 mM
PMSF, 0.5-1 % PIP
ion exchange buﬀer1
and 2
buﬀer1: 40 mM Hepes/KOH pH 7.4
buﬀer2: 40 mM Hepes/KOH pH 7.4, 2000 mM KOAc
gel ﬁltratton buﬀer 40 mM Hepes/KOH pH 7.4, 100 mM NaCl
Table 3.: Overview of buﬀers.
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8.1.3. Gel electrophoresis
SDS-PAGE Denaturing discontinuous SDS-PAGE (SDS polyacrylamide gel electrophore-
sis) was used to separate proteins according to their molecular weights, using standard
protocols (Laemmli, 1970). Samples were denatured at 94°C for 4 min, containing 1x
sample buﬀer, and loaded on 12 or 15 % polyacrylamide gels. Electrophoresis was per-
formed at constant voltage of 120-200 V in standard running buﬀer (25 mM Tris, 192
mM glycine, 0.1 % SDS).
Agarose gel electrophoresis Agarose gel electrophoresis was used to separate DNA
and RNA according to their size. Gels were made with 1-2 % agarose in TAE buﬀer
and run for circa 20-40 min at 50 V constant voltage. DNA and RNA molecules were
stained with SYBR Green I and II (Molecular Probes), respectively and visualized at a
wavelength of 300 nm. DNA markers (Biorad and NEB) were used as molecular weight
standards.
8.1.4. Genetic experiments
Yeast cloning was done using kits and standard methods. The cloned constructs were
checked by a commercial sequencing service (Euroﬁns MWG Operon).
Cloning The PCR ampliﬁed DNA and the plasmid was digested by restriction digest.
A typical 200 µl digestion reaction was composed of 3 µg DNA template, 30 U restriction
enzyme, an appropriate 10x buﬀer and nuclease free H2O and incubated for 2 h at
37°C. The digestion reaction was puriﬁed via a PCR puriﬁcation kit (QIAquick® PCR
puriﬁcation kit, Quiagen) and the puriﬁed digestion products were ligated. For a normal
20 µl kit based ligation reaction (Fermentas), a ﬁve fold molar excess of the insert over
the plasmid was used, 2 µl 10x ligation buﬀer, 2 µl 50 % PEG, 5 U T4 ligase and ddH2O
were used. The ligation approach was used for transformation of chemical competent E.
coli cells (DH5a or TOP-10F kit cells, Invitrogen). The cells were gently thawed on ice,
1/2 of the ligation reaction was added to 50 µl cells, then the reaction was incubated for
10 min on ice and immediately transfered to 42°C water bath for heat shock. Around
1 ml of LB or SOC media (Fermentas kit) was added and the cells recovered while
incubating for 30 min at 37°C (Eppendorf Thermomixer). The cell pellet (30 s at 3000
rpm, Eppendorf table top centrifuge) was resupended in 100 µl LB media and plated
onto a selection agar plate for overnight growth at 37°C. Around 10 ml LB media with
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primer 5'-3' sequence
L25_fw CGC GGATCC CATGGGTCACTTATTTAATATGTACGGGTGTTTACATGG
L25_rv CGC GGATCC GTT GCT GAT GAA AAT AAC CCT GTG TTT TCG C
rpL25-NotI_fw GATCGGCGGCCGCCATGGGTCACTTATTTAATATGTAC
rpL25-NcoI-L-
BamHI_rv
CCTTGGAAAACACCTTCAGCCATGGATCCGGACCCTCCGCCACCGGGCCCCTGGAAC
AGAACTTCCAGCCATGGAATGTAACCGATTCTGTTAGCAATGTCC
Ssb1-BamHI_fw GGTGGCGGAGGGTCCGGATCCATGGCTGAAGGTGTTTTCCAAGG
Ssb1-XhoI_rv CTAGCCTCGAGCTATTAACGAGAAGACATGGCCTTG
Table 4.: Sequences of primers.
antibiotics was inoculated with a single colony and incubated at 37°C overnight. Plasmid
were extracted form the overnight cultures using a kit (QIAprep® Spin Miniprep kit,
Quiagen) and the puriﬁed plasmids were analyzed by restriction digest combined with
agarose gel electrophoresis.
Yeast strain with RPL25-SSB1 fusion (BY_L25-SSB1) Yeast cells were geneti-
cally modiﬁed to generate 80S ribosomes with a fusion of Ssb1 to the ribosomal exit
tunnel protein rpL25. The ribosomal protein RPL25 was ampliﬁed from genomic DNA
(primer L25_fw and L25_rv) and cloned into a pRS316(CEN, URA3) plasmid using
BamHI restriction sites, which resulted in the vector pRS316-L25. A heterozygous
diploid yeast strain with only one copy of RPL25 (BY4743, RPL25::kanMX4/rpl25;
Y26277 Euroscarf) was transformed with pRS316-L25 to generate the strain BY_L25
(RPL25::kanMX4/rpl25 pRS316-L25). The strain BY_L25 was sporulated and tetrads
were dissected to get haploid cells of BY_L25 (Drpl25 pRS316-L25), having the only
copy of the essential gene RPL25 on the plasmid pRS316-L25. The tetrads were analyzed
under selective conditions (G418 and FOA) and glycerol stocks of positive tetrads were
invested and stored at -80°C. RPL25 was ampliﬁed with the primer rpL25-NotI_fw and
rpL25-NcoI-L-BamHI_rv, and cloned into pRS315(CEN, LEU2) to generate the plasmid
pRS315_linker. SSB1 was ampliﬁed from an existing vector (pYCPlac33-SSB1(CEN,
URA3), Rospert group) using the primers Ssb1-BamHI_fw and Ssb1-XhoI_rv, and in-
serted into the plasmid pRS315_linker to generate the plasmid pRS315-L25-SSB1. The
ribosomal protein rpL25 was fused via its C-terminus to Ssb1. The strain BY_L25
(Drpl25 pRS316-L25) was then transformed with the plasmid pRS315-L25-SSB1. The
transformed BY_L25 cells were shifted to FOA plates and incubated at 25°C. The
rpL25-Ssb1 fusion protein (pRS315-L25-SSB1) complemented for rpL25 and the grown
colonies were analyzed under selective conditions (LEU, URA and G418), to get the
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strain BY_L25-SSB1 (Drpl25 pRS315-L25-SSB1).
8.2. Puriﬁcation
8.2.1. Western blot (WB)
Western blot was used for the qualitative detection of tagged nascent chains to track
the RNC puriﬁcation or to check the result of an in vitro test translation reaction. For
HA tag detection, SDS gels were blotted for 45 min at 75 V constant voltage per gel,
in blotting buﬀer on PVDF membranes, using a standard semi-dry blotting apparatus.
Membranes were then stained for 1 min in Amido black, digitized, destained and blocked
with 2 % BSA in 1x TBS buﬀer. The primary antibody (HA-probe (F-7) mouse ab,
Santa Cruz Biotechnology) was used in a 1:1000 dilution in 2 % BSA (1x TBS) and
incubated overnight at 4°C. The membrane was washed three times á 10 min with 1x
TBS-T buﬀer and the second antibody (goat anti-mouse antibody) was used in a 1:2000
dilution in 5 % milk (in 1x TBS; Roth) and incubated for > 1 h at RT. Membranes
were washed again three times with TBS-T buﬀer and signals were detected by ECL
reaction (self-made solutions or Chemiluminescent Detection kit, AppliChem) and ﬁlms
(GE Healthcare).
8.2.2. TCA precipitation
TCA precipitation was used prior to western blot analysis or reconstitution experiments,
to concentrate proteins out of highly diluted reaction mixtures. To each reaction, 150-200
µl of 72 % trichlor acetic acid (TCA) and 0,15 % natrium deoxycholate were added and
the overall volume was adjusted to 1 ml with ddH2O. Reactions were incubated overnight
at -20°C, centrifuged, the resulting pellet was washed once with 100 % acetone p.a. and
ﬁnally 10 µl sample buﬀer was added to the dried pellet for SDS-PAGE.
8.2.3. SYPRO orange staining
The SDS gels were stained with SYPRO orange for detection of small amounts of proteins
(< 100 ng per 0.5 cm lane), used in reconstitution assays. Gels were washed for 1 min
in 7.5 % acetic acid and stained in the dark for > 1 h at RT, in a solution of 1:5000
SYPRO orange in 7.5 % acetic acid. The gels were washed for 30 s in 7.5 % acetic
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acid and visualized at 480 nm excitation wavelength (580 nm emission ﬁlter, 590 V
sensitivity) with a Typhoon scanner (Typhoon 9400, Amersham).
8.2.4. Preparation of yeast translation extract (YTE)
A YTE was prepared to utilize an in vitro translation, enabling us to purify yeast 80S
RNCs. Two well-aerated 10 L bottles were inoculated with an overnight pre-culture to
ODstart of < 0.03 OD600. The cells were harvested after overnight growth at 30°C at
1.5-2 OD600. Around 20 L of yeast cells were harvested in several runs (10 min at 5000
rpm, 4°C, SLC-6000 rotor), using 1 L buckets, and washed with cold water. The pooled
cells were weighted in 500 ml buckets, washed with cold 1 % KCl, resuspended in buﬀer
PD (around 200 ml buﬀer PD per 50 g cells) and incubated for 15 min at RT. Cells were
centrifuged (10 min, 5000 rpm, GS3 rotor) and resuspended, using 1 ml YPD/sorbitol
per 0.3 g cells. To digest the cell wall and generate spheroblasts, 0.625 mg zymolyase
(20,000 U/g (20 T), MP Biomedicals) was added per 1 ml volume and the reaction was
incubated for 1 h at 30°C. After 5 min on ice, the cells were centrifuged (10 min, 5000
rpm, GS3 rotor) and washed three times with 200 ml of YPD/sorbitol. The cells were
resuspended in YPD/sorbitol and incubated for 1 h at 30°C for recovery. The cells were
washed with 1M sorbitol and then resuspended in a small volume of YTE-lysis buﬀer
(< 10 ml per 50 g cells). Cells were lysed with manually with around 15 strokes in a
tight glas douncer (40 ml douncer, Wheaton USA) and centrifuged (15 min at 15,500
rpm, SS-34 rotor). The supernatant was transfered and ultra-centrifuged to isolated the
cytosolic fraction (30 min at 37,000 rpm, 4°C, Ti70 rotor). Only the clear fraction of
the supernatant was carefully isolated (YTE) and the concentration was determined at
OD280. Finally, PD-10 gel ﬁltration columns were equilibrated three times with 5 ml
TE buﬀer, then 2.5 ml of the YTE was loaded on one column, the column was washed
with 0.75 ml TE buﬀer, 2 ml TE buﬀer was added and the ﬂow through was collected.
Again OD280 was determined and the endogenous mRNA of the YTE was digested by
S7 nuclease treatment, using normally 10 U S7 nuclease per ml YTE. The YTE was
adjusted to 0.8 mM CaCl2, S7 nuclease was added, the reaction was incubated for 15
min at RT and stopped by incubation on ice plus adjusted to 2 mM EGTA (pH 8.0).
Aliquots were ﬂash frozen in liquid N2 and stored at -80°C.
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component volume (µl)
12,5 x E-Mix (energy
providing)
96
25 x CB (compensation
buﬀer)
48
amino acid mix 48
1 M Tris pH 6.8 48
RNAsin 10
YTE 400
anti-RNAsin (Ambion) 10
ddH2O ad 1200
mRNA 4.8 µg per 100 µl volume
Table 6.: Reaction mix of a typical 1.2 ml in vitro translation reaction used for RNC
puriﬁcation.
8.2.5. Puriﬁcation of 80S RNCs
Cell free in vitro translation reaction (IVT) based on a self-made YTE, was used to
program yeast 80S ribosomes by the use of speciﬁc truncated mRNA without a stop
codon, as previously described (Beckmann et al., 1997). A typical in vitro translation
reaction for RNC puriﬁcation was composed as shown in table 6.
The IVT mix was incubated in 100 µl PCR tubes at 17-20°C for 75 min, then pooled
and stopped by adding 4 µl of 10 mg/ml cycloheximid per 100 µl reaction volume. 80S
ribosomes were pelleted by centrifugation (45 min at 100,000 rpm, 4°C, TLA 120.2 rotor),
loading 200 µl IVT mix onto 800 µl 1 M sucrose cushion (6 tubes) and each pellet was
resuspended in 500 µl 250 buﬀer by incubation for 45 min on ice. Two columns (BioRad)
were loaded each with 1 ml resin material (TALON metal aﬃnity resin, Clontech),
equilibrated with 5 ml 250/tRNA buﬀer to minimize unspeciﬁc binding. Around 1.5
ml of the resuspended 80S were loaded on one column and the reaction was agitated
for 5 min at RT. Next, the ﬂow through was collected, the columns were washed each
with 1.5 ml 250 buﬀer, followed by an intensive washing procedure (12 ml 250 buﬀer
and high salt wash with 3.5 ml 500 buﬀer per column). The bound RNCs were eluted
by addition of 1,5 ml 250/100 buﬀer, whereby the columns were agitated for 5 min at
RT. The ﬂow through was collected, again 2.25 ml of 250/100 buﬀer was added, the
complete collected ﬂow through was centrifuged to isolate the 80S RNCs (around 3 ml
eluate loaded onto 500 µl 1 M sucrose cushion; 45 min at 100,000 rpm, 4°C, TLA 100.4
rotor) and the supernatant was immediately removed. The pellets were resuspended in
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a small volume of grid buﬀer by incubation for 45 min on ice. Concentration of the
pooled RNCs was determined at OD260 and small aliquots were ﬂash frozen in liquid
N2 and stored at -80°C. The average yield of a 1.2 ml yeast IVT reaction was between
1.5 to more than 2 OD260. An aliquot was taken at each step of the puriﬁcation and a
negative control was run without mRNA, the samples were analyzed by SDS-PAGE and
western blot.
The puriﬁcation of wheat germ 80S RNCs followed exactly the same protocol, except
for some minor variations: the reaction mix had a diﬀerent composition (1.2 ml reaction:
600 µl wheat germ extract (Ambion kit or self-made wheat germ extract), 60 µl aa mix,
1M KOAc pH 7.0, 4µg/ml mRNA, with ddH2O ad 1200 µl volume) and the incubation
was conducted at 26°C for 45 min.
80S DPAP RNCs A forward T7 standard primer and a speciﬁc reverse primer were
used to generate DPAP constructs of diﬀerent length (DPAP90 and 120) and PGK
constructs. The RNC puriﬁcation followed the protocol, described before.
80S Helix RNCs The helix1 construct was chemically synthesized by Euroﬁns (Mar-
tinsried, Germany). DNA template for transcription was prepared using T7 standard
and reverse (5'-ATCGTAGACAGATTTAACAAC-3') primers by PCR. The helix2 con-
struct was generated by PCR using a standard T7 primer with a modiﬁed reverse (5'-
ATCGTACTCGAGACCACCAGCTTTAG-3') primer, with helix1 construct as the tem-
plate. Uncapped transcripts were then synthesized from the PCR fragments using T7
RNA polymerase. 80S Helix-RNCs were generated using a self-made wheat germ in
vitro translation system programmed with truncated mRNA encoding the helix1 and 2
regions. RNCs were puriﬁed as described before.
8.2.6. Isolation of 80S ribosomes
Eukaryotic 80S ribosomes were puriﬁed from diﬀerent yeast strains, applying basically
the following protocol. The modiﬁed 80S-Ssb1 ribosomes were isolated the following
way from the RPL25-Ssb1 fusion strain. Around 2 L of YPD were inoculated and grown
until 1.4 OD600. The cells were harvested (10 min at 5000 rpm, 4°C, GS3 rotor, washed
with cold water and 1 % KCl. The pellet was resuspended in buﬀer PD and incubated
for 15 min at RT. After centrifugation (10 min at 5000 rpm, 4°C, GS3 rotor), the cells
were resuspended in 80S-lysis buﬀer and lysed with a three frensh press runs using a
pressure of 18 kPsi. The lysate was centrifuged (15 min at 15,500 rpm, 4°C, SS-34 rotor)
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and the supernatant was ultra-centrifuged (38 min at 37,000 rpm, 4°C, Ti70 rotor). The
resulting supernatant was subsequently layered onto a 80S-sucrose cushion, composed
of a 3 ml 2M 80S-sucrose cushion layered with 3 ml 1.5 M 80S-sucrose cushion, and
ultra-centrifuged (20 h at 50,600 rpm, 4°C, Ti70 rotor). The ribosome pellets were
resuspended in nuclease free H2O, the concentration was determined at OD260, 20 µl
aliquots were ﬂash frozen in liquid N2 and stored at -80°C. The quality of the ribosome
preparation was analyzed by SDS-PAGE and the fusion was additionally conﬁrmed by
western blot, using a poly-clonal anti-Ssb antibody serum (Rospert group).
8.2.7. Puriﬁcation of RAC and SAXS analysis
RAC puriﬁcation The protein complex RAC (Zuo and Ssz) was over-expressed in
E.coli Rosetta 2 (DE3) cells (Chl), using two separate plasmids for each subunit of the
complex (protocol from the Rospert group). Around 50µl of electro-competent E.coli
cells were transformed by electroporation with a 2.5 kV pulse (0.2 cm Gene Pulser
cuvette, BioRad, USA), using the two plasmids pETcoco2-Zuo1(Amp) and pET28N-
Ssz1(Kan), encoding for Zuotin and Ssz, respectively (plasmids were a kind gift of the
Rospert group in Freiburg). Immediately 1 ml of cold LB media was added and the cells
were incubated for 30 to 45 min at 37°C, for recovery. The cells were harvested in a
tabletop centrifuge at 4000 rpm and resuspended in 100 µl fresh LB media. Cells were
plated for selective growth on LB plates, containing in the case of RAC over-expression
the three antibiotics kanamycin (Kan), ampicillin (Amp) and chloramphenicol (Chl),
and incubated overnight at 37°C.
RAC was co-puriﬁed in a four step protocol without a tag, using basically a previously
described protocol with minor changes (Conz et al., 2007). After selective growth on LB
plates, E.coli cells from the LB plate were used to inoculate 10 ml overnight cultures.
These pre-cultures were then used to inoculate 1L expression cultures with OD(start)600
of around 0.05. The cells grew at 37°C and the expression was induced at an OD600
of 0.5 - 0.7 by adding IPTG (Roth) to a ﬁnal concentration of 0.5 - 1 mM to the
cultures. Then the cells grew further at 26°C and were harvested after 4 hours of growth
by centrifugation runs (4000 rpm, 10 min, SLC-6000 rotor, Sorvall). The cells were
resuspended once in LB media and the cell pellets were ﬂash frozen in liquid nitrogen
and stored at -80°C. The RAC E.coli cell pellets were thawed and resuspended in 1
ml RAC-lysis buﬀer per 1 g cell pellet, on ice. Lysozyme (Sigma-Aldrich), using 1
mg/ml ﬁnal concentration, was added and the cells were incubated for 30 min. The
cells were lysed using at least three frensh press runs (18 kpsi, Microﬂuidics, USA) or by
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soniﬁcation (9 cycles each 20 s (35 - 40 %) with a cooling step after each cycle of 20 - 30
s, HD200, Bandelin, Germany). The lysate was treated with 1 µl nuclease (benzonase,
Sigma-Aldrich)) and the cells were incubated for 10 min at RT and 20 min on ice. The
lysate was cleared by two centrifugation steps (1.: 18.000 rpm, 15 min, SS-34 rotor; 2.:
18.000 rpm, 5 min, SS-34 rotor). The remaining supernatant was ﬁltered (0.45 µm ﬁlter,
Millex-HA, Millipore) and the cleaned lysate was loaded onto a 6 ml Resource Q anion-
exchange column (GE Healthcare) using an ÄKTA puriﬁer system (ÄKTA, Sweden).
Samples were eluted with an 0 - 40 % linear salt gradient (0 - 800 mM KOAc, using
ion exchange buﬀer1 and 2). After analysis of the peak fraction by SDS-PAGE, the
fractions were pooled and diluted with ion exchange buﬀer1 to a ﬁnal concentration of
200 mM KOAc, to decrease the salt concentration for the next step. The pooled RAC
containing fractions were loaded onto a second anion-exchange column (POROS HQ 20)
and RAC was eluted by a 10 - 80 % linear KOAc gradient (200 - 1600 mM KOAc, using
ion exchange buﬀer1 and 2). After analysis of the peak fraction by SDS-PAGE, the RAC
fractions were pooled and adjusted to around 100 mM KOAc with ion exchange buﬀer1.
The diluted RAC fraction was loaded onto a cation-exchange column (POROS HS 20),
and RAC was eluted with a 0 - 60 % linear KOAc gradient (0 - 1200 mM KOAc, using
ion exchange buﬀer1 and 2). Peak fractions were analyzed, pooled and concentrated to
a RAC concentration of about 3-5 mg/ml using centrifuge ﬁlter devices with a molecular
weight cut-oﬀ of 10 kDa (Amicon Ultra-4, Millipore; 1500 rpm in a 4444 rotor, Hettich
centrifuge). The protein concentration was measured at l280 and the concentrated eluate
was loaded onto a Superdex 200 10/300 GL gel ﬁltration column (GE Healthcare), using
the gel ﬁltration buﬀer. Finally, the peak fraction was analyzed by SDS-PAGE and the
protein was stored at -80°C.
SAXS analysis SAXS datasets for RAC and the deletion mutant were collected at
the DESY in Hamburg (Bio-SAXS beamline, EMBL) with the help of Gregor Witte
(Hopfner group). The raw data, including the one-dimensional scattering curves, were
initially processed with the software packages PRIMUS and GNOM (Konarev et al.,
2003; Semenyuk & Svergun, 1991). The program PRIMUS was used for data reduction.
Then data regularization was done with the program GNOM. The ﬁrst ab initio structure
calculation was done the software DAMMIN (Svergun, 1999; Volkov & Svergun, 2003),
which calculates a model by densely packed dummy atoms (beads). Afterwards the
program GASBOR (Svergun, 2001) was used to calculate detailed models, where each
residue is represented by a dummy residue that results in a chain compatible model.
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component amount per reaction
yeast 80S RNCs 1-1.5 pmol
RAC 10 x excess over 80S
Ssb1 10 x excess over 80S
100K-BA buﬀer ad 25 µl volume
Table 8.: Example of a typical 25 µl reconstitution reaction.
Each dummy residue aims to be positioned approximately at the Ca atom of the protein
structure.
8.3. Reconstitution experiments
Reconstitution experiments (also called binding or pelleting assay) were used to analyze
co-pelleting of ribosome-binding factors with 80S ribosomes. The basic experimental
setup was in case of the RAC binding assays as follows: ﬁrst, the components were
added stepwise to a low (e.g. 100K-BA buﬀer) or high salt buﬀer (same as 100K-BA
buﬀer but with 300-500 mM KOAc) and incubated for 10 min at RT and 10 min on
ice, then the 25 µl reconstitution reaction was loaded onto 600µl of a 750 mM sucrose
cushion and centrifuged (135 min at 40,000 rpm, 4°C, SW-55 Ti rotor), to pellet the
ribosomes. After centrifugation, the tubes (Beckman Coulter) were immediately ﬂash
frozen in liquid N2 and cut into two parts with a scalpel. All reactions were TCA
precipitated and analyzed by SDS-PAGE followed by SYPRO orange staining.
80S RNC RAC complexes The 80S DPAP-RNC RAC-Ssb1 complex was reconsti-
tuted in a 25 µl reaction, using 1.4 pmol 80S DPAP120 RNCs, 10 pmol RAC, 10 pmol
Ssb1 and 100K-BA buﬀer, containing 1 mM AMPPNP. The wg80S mRAC complex was
reconstituted with 3 pmol DPAP90-RNCs, 30 pmol mRAC and 100 K-BA buﬀer, in-
cluding 1 mM AMPPNP. To reconstitute the 80S rpL25-Ssb1 RAC complex, 2 pmol of
80S rpL25-Ssb1 ribosomes were incubated with 20 pmol of RAC and 100K-BA buﬀer.
60S-eIF6 complex The sample for cryo-EM analysis was prepared by incubation (10
min at RT) of ∼2 pmol gradient-puriﬁed 60S subunits with ∼10 pmol of puriﬁed eIF6.
The 60S-eIF6 complex was reconstituted in buﬀer A containing 100 mM KCl. The
reconstituted samples were immediately applied to the grid and ﬂash frozen in liquid
ethane using a computer controlled automated vitrobot system (FEI).
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9. Cryo electron microscopy
9.1. Negative stain electron microscopy
Negative stain EM was used to pre-analyze the samples before the grids were prepared
for cryo-EM. The grid surfaces were cleaned with a plasma cleaner (Harrick Plasma,
USA) at 0.22 Torr for 45 s. 3.5 ml of the sample were applied to a freshly cleaned grid
and incubated for 45 s and the grid was then washed with ﬁve drops of water. After the
washing step, the grid was stained with three drops of uranyl acetate (Ted Pella, Inc.,
USA) for 15 s and dried by carefully sliding blotting paper along the tweezers holding it.
The grid was then allowed to dry on blotting paper for 5 min. Analysis of negative stain
grids was done on a Spirit microscope (FEI Tecnai G12 Spirit 120 kV cryo-microscope)
or on a Morgagni microscope (100 kV FEI Morgagni electron microscope) in Munich.
9.2. Data collection
3,5 µl of the reconstituted samples were applied to carbon coated holey grids as described
(Grassucci et al., 2007). Datasets were collected on a FEI Tecnai F30 ﬁeld emission gun
cryo-microscope at 300 kV in Berlin (F30 microscope, Ultrastruktur Netzwerk) or on a
FEI Tecnai G2 Spirit 120 kV cryo-microscope (Spirit microscope, Munich) under low
dose conditions with ∼20 e−/Å2 in a defocus range between 1.0 mm and 4.5 mm. The
micrographs were developed and digitized on a Heidelberg drum scanner resulting in a
pixel size of 1.24 Å/pixel on object scale.
9.3. Data processing
High resolution datasets of the Tecnai F30 microscope were pre-processed using the
following main SPIDER (Frank et al., 1996) scripts in that order: 1. p_ctﬃnd.rib
(byteswap.sh, p_readmrc.py, ctﬃnd.sh) uses CTFFIND (Mindell & Grigorieﬀ, 2003)
for CTF determination, 2. visual inspection of power spectra was done in WEB and the
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micsuse ﬁle was cleaned for micrographs with bad quality power spectra, 3. the script
sig_decimate.rib generated two times decimated micrographs converted to mrc format,
which were used for half-automated SIGNATURE screening with the script sig_pick.rib,
4. screened micrographs were loaded in SIGNATURE (Chen & Grigorieﬀ, 2007) and
coordinates were saved for each particle of the micrograph, 5. these coordinates were
used by the script p_window.rib (noise ﬁle, p_convert_inline.rib), to cut out single
particles, 6. particles were ﬁltered and decimated (p_dcsﬂt.rib) for visual selection of
bad particles with WEB (Frank et al., 1996), 7. the script p_copygood.rib removed the
bad particles from the overall dataset and renumbered the leftover particles, by moving
them into good folders (good, goodparts and goodpartscoord folder), 9. the script
p_makedefgrpﬁle.rib generates a defocusgroup ﬁle (defgroup.rib) out of the defocus ﬁle
(defocusﬁle.rib), whereby the micrographs were grouped manually according to their
defocus value.
Initial alignment Three fold decimated particles were initially aligned by the use of
the script p_alidef.rib, using cross-correalation based projection matching technique
(AP MQ command), whereby 83 reference projections of a template 3D volume were
used, corresponding to an angular accuracy of 15°. The resulting apmq ﬁles contained
for each particle the alignment information, comprising the best matching projection,
an un-normalized CCC value, as well as the in-plane rotation angle and x,y-shifts in
pixels. The rotation and shifts parameters were applied to generate a 3D reconstruction
with the scripts p_maketrans.rib, p_spinnem.rib (p_angles.rib) and ﬁnally bp3f_n.rib
(ref_rotate.rib; trans-, angles and select ﬁles and good folders as input) by backprojec-
tion of the particles. The resolution of each defocus group was calculated by comparing
the backprojected volumes of the two random halfsets of each defocus group, the sub-
volumes of each defocus group were CTF corrected and summarized to a ﬁnal volume.
Reﬁnement Large dataset were reﬁned on a high performance Intel/Opteron com-
puter cluster with several hundred processors. Reﬁnement of the datasets was realized
by iterative rounds of alignment and backprojection, whereby the masked and ﬁltered
output volume was used as input for the next reﬁnement round, aiming to improve the
resolution of the output 3D reconstruction. The trans ﬁles contained shifts and rotation
parameters, which were applied to the original undecimated particles for backprojection
to avoid a loss of information, if interpolation would be used. Filter parameter and
alignment algorithms were varied, the angular increments and restrictions were succes-
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sively decreased, resulting in a more accurate sampling of the projection space due to
the increased number of compared reference projections. Supervised sorting was used to
classify the datasets, e.g. in case of P-tRNA sorting was an un-programmed 80S volume
used as reference.
Low resolution datasets were collected on a Tecnai Spirit cryo-microscope at 120 kV
in Munich (Biozentrum). The work ﬂow for Spirit datasets was the same as previously
described for the processing of the Tecnai F30 data, but with the following variations:
1. inversion of the particle contrast was done with the script (cp_to_negative.rib),
necessary for SIGNATURE, 2. no visual particle inspection was done, badly windowed
particle were automatically removed by the script p_edgepartscreen.rib.
Interpretation and modeling Cryo-EM densities were isolated using binary masks.
Initial docking of atomic structures and models into EM densities was done with the
program Coot (Emsley et al., 2004). The generated models were in some cases reﬁned
and ﬁtted with MDFF (Trabuco et al., 2008). The programs Chimera (Pettersen et al.,
2004) and PyMol (http://www.pymol.org) were used to prepare ﬁgures. In the 80S
RNC-Helix study, homology models for ribosomal proteins were built using MODELLER
(Eswar et al., 2007), after protein alignment with T-Coﬀee (Notredame et al., 2000).
Models were then adjusted manually with Coot and minimized with VMD (Humphrey
et al., 1996).
9.3.1. Sorting of the datasets
All datasets were processed according to the workﬂow described before, using a super-
vised sorting strategy.
60S-eIF6 complex The dataset of the 60S-eIF6 complex was classiﬁed into two sub-
datasets, with 31,000 particles in the 80S sub-dataset and 76,000 particles containing
the 60S-eIF6 complex. Densities for the 60S subunit and eIF6 were isolated using binary
masks.
80S Helix-RNCs Removal of empty ribosomal particles resulted in 120,000, 190,000
and 150,000 programmed particles for the 80S Helix1-RNC, 80S Helix2-RNC and 80S
DPAP-RNC datasets, respectively. Densities for the 40S subunit, the 60S subunit
and the P-site tRNA were isolated using binary masks. The homology model for the
79
III CHAPTER 9. CRYO ELECTRON MICROSCOPY
(EAAAK)5 helix was built on the basis of the HPLC6 sequence using HHPred server
and ﬁtted into to the assigned EM density.
80S RAC datasets The dataset of the wg80S RNC mRAC complex, with all together
59,000 particles, was sorted for the presence of P-tRNA, resulting in 47,000 particles
for programmed and 12,000 particles for un-programmed 'empty' 80S ribosomes, re-
spectively. The dataset of 80S DPAP-RNC RAC-Ssb1 dataset with 50,000 particles
was sorted ﬁrst for ES27 density, resulting in 34,000 particles for the ES27 in L1 con-
formation and 16,000 particles and its exit conformation, respectively. The ES27-L1
sub-dataset was further classiﬁed for the presence of RAC density, revealing that around
18,000 particles with present showing additional RAC density and 16,000 particles did
not show extra ligand density, respectively. The Spirit dataset of the 80S rpL25-Ssb1
RAC complex with overall around 14,000 particles was sorted for the presence of the
two distinct ES27 conformations, resulting in 3,100 and 10,700 particles for the ES27 in
exit and L1 conformation, respectively.
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Index
80S-Ssb1 - 80S ribosomes with N-terminal
fusion of Ssb1 to rpL25, 52
aa - amino acid(s), 8
CCC- Cross-correlation coeﬃcient, 21
CCD - charge-coupled device, 18
CCF - cross-correlation function, 19
cryo-EM - cryo-electron microscopy, 6
CTF - contrast transfer function, 19
DLS - dynamic light scattering, 46
DPAP - Dipeptidyl aminopeptidase of yeast,
49
DPAP-B - dipeptidyl-aminopeptidase B
from yeast, 34
Eﬂ1 - elongation factor-like 1 (Eﬂ1p in
yeast), 10
eIF6 - eukaryotic translation initiation
factor 6, 9
EM - electron microscopy, 75
ES27 - eukaryotic expansion segment 27
of the 28S rRNA, 54
FSC - Fourier shell correlation, 21
IVT - in vitro translation reaction, 70
kDa - kilo Dalton, 17
KOAc - potassium acetate, 65
mRAC - mammalian ribosome associated
complex (MPP11 and Hsp70L1),
15
mRNA - messenger RNA, 8
MW - molecular weight, 8
NAC - nascent polypeptide-associated com-
plex, 14
nascent chain - nascent polypeptide chain
of the translating ribosome, 45
NBD - nucleotide binding domain, 14
NEFs - nucleotide exchange factors, 15
PCR - Polymerase chain reaction, 64
PDF - peptidyl deformylase, 61
PIP - complete protease inhibitor pill (Roche),
65
PTC - peptidyl transferase center, 8
RAC - ribosome associated complex, 15
RACK1 - Receptor for activated protein
kinase C, 10
RACMZuo110 - complex of the ﬁrst 110
aa of Zuo and Ssz, 47
RPBs - ribosome-associated protein bio-
genesis factors, 15
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rpL23 - eukaryotic ribosomal protein L23
of large subunit (L14 in E. coli
and RpL23p in S. cerevisiae nomen-
clature), 25
rpL24 - eukaryotic ribosomal protein L24
of large subunit (RpL24p in S.
cerevisiae nomenclature; no bac-
terial homolog ), 27
rRNA - ribosomal RNA, 10
RT - room temperature, 25
S - Svedberg constant, unit, 8
S. cerevisiae - Saccharomyces cerevisiae
(species of budding yeast; baker's
yeast), 15
SAXS - small angle X-ray scattering, 45
SBD - substrate binding domain, 14
SBDS - Shwachman-Bodian-Diamond syn-
drome, 10
SDS-PAGE - sodium dodecyl sulfate poly-
acrylamide gel electrophoresis, 66
SNR - signal-to-noise ratio, 17
SRL - sarcin-ricin loop, 27
SRP - signal recognition particle, 15
Ssb - Ssb1p and Ssb2p in S. cerevisiae,
14
TEM - transmission electron microscope,
18
TF - Trigger factor, 13
WB - Western Blot, 68
wg80S/wgRNC - 80S ribosomes or RNCs
from wheat germ (Triticum aes-
tivum), 49
y80S/yRNCs - 80S ribosomes or RNCs
from yeast, 50
YTE - yeast translation extract, 69
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